1
|
Clottes P, Bochaton T, Mechtouff L, Derex L, Cho TH, Fontaine J, Rascle L, Berthezène Y, Amaz C, Thibault H, Bergerot C, Nighoghossian N, Ong E. Safety and efficacy of reperfusion therapies in acute ischemic stroke related to left ventricular thrombus: A retrospective cohort study. Rev Neurol (Paris) 2024:S0035-3787(24)00417-X. [PMID: 38431497 DOI: 10.1016/j.neurol.2023.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 12/04/2023] [Accepted: 12/17/2023] [Indexed: 03/05/2024]
Abstract
BACKGROUND Left ventricular thrombus (LVT) is a source of cardiogenic embolic stroke. Conflicting data exist in the literature regarding the utilization of intravenous thrombolysis (IVT) at the acute phase of stroke in presence of LVT. We sought to assess the efficacy and safety of reperfusion therapies (IVT and/or thrombectomy) in patients with LVT. METHODS We retrospectively analyzed patients with acute ischemic stroke and proven LVT and divided them in two groups: an intervention group with patients treated by reperfusion therapies and a control group with untreated patients. RESULTS Between 2009 and 2021, 3890 patients were treated by reperfusion therapies in the Lyon stroke center, 33 of whom (0.9%) had LVT. We identified 27 control patients. There were more embolic recurrences at six months in the intervention group than in the control group (nine recurrences versus three, P=0.03, OR=13.56, 95% CI [1.5;195]). Only two early embolic recurrences (< 24h) occurred, both in the IVT group. There was a 4.8-fold decrease in the median NIHSS score between baseline and 24h follow-up in the intervention group (P<0.0001), and the two groups exhibited similar six-month mortality. At stroke onset, cardiopathy was known in 70% of patients, while LVT was known in 30%. CONCLUSION Acute reperfusion therapies seem to be effective in the context of stroke in patients with LVT. However, further studies are needed to support the hypothesis that stroke recurrence might be related to the use of IVT.
Collapse
Affiliation(s)
- P Clottes
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France.
| | - T Bochaton
- Service d'urgences cardiologiques et de soins intensifs de cardiologie, hôpital Louis-Pradel, 59, boulevard Pinel, 69500 Bron, France
| | - L Mechtouff
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - L Derex
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - T-H Cho
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - J Fontaine
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - L Rascle
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - Y Berthezène
- Service d'imagerie médicale, 59, boulevard Pinel, 69500 Bron, France
| | - C Amaz
- Centre d'investigations cliniques, hôpital Louis-Pradel, 59, boulevard Pinel, 69500 Bron, France
| | - H Thibault
- Service des explorations fonctionnelles cardiovasculaires, hôpital Louis-Pradel, 59, boulevard Pinel, 69500 Bron, France
| | - C Bergerot
- Service des explorations fonctionnelles cardiovasculaires, hôpital Louis-Pradel, 59, boulevard Pinel, 69500 Bron, France
| | - N Nighoghossian
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| | - E Ong
- Service de neurologie vasculaire, hôpital Pierre-Wertheimer, 59, boulevard Pinel, 69500 Bron, France
| |
Collapse
|
2
|
Leboube S, Camboulives L, Bochaton T, Amaz C, Bergerot C, Altman M, Loppinet T, Cherpaz M, Monsec T, Sportouch C, Trinh A, Soulier C, Bernard A, Derumeaux G, Mewton N, Ovize M, Thibault H. What underlies sex differences in heart failure onset within the first year after a first myocardial infarction? Front Cardiovasc Med 2024; 10:1290375. [PMID: 38322272 PMCID: PMC10844509 DOI: 10.3389/fcvm.2023.1290375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 12/13/2023] [Indexed: 02/08/2024] Open
Abstract
Background Women are more likely to develop heart failure (HF) after myocardial infarction. However, diagnosis and reperfusion are often delayed. Objectives To compare the prevalence of HF after primary percutaneous coronary intervention (PPCI)-treated ST segment myocardial infarction (STEMI) between sexes and to study its associations with comorbidities, infarct size, and left ventricular (LV) systolic and diastolic dysfunctions (DD). Methods The patients with PPCI-treated anterior STEMI, from the CIRCUS study cohort, were followed up for 1 year and HF events were recorded. Evaluation of ejection fraction (LVEF) and DD were performed at baseline and at 1 year. The elevated LV filling pressure (LVFP) included Grades 2 and 3 DD. Results Of the 791 patients from the CIRCUS study, 135 were women. At 1 year, the proportion of patients who developed HF was 21% among men and 34% among women (p = 0.001). In the subset of 407 patients with available diastolic parameters, the rate of HF was also higher in women. HF during the initial hospitalization was comparable between the sexes. However, women had a higher incidence of rehospitalization for HF within the first year after STEMI (14.1% vs. 4.1%, p = 0.005). Women were older with a higher prevalence of hypertension. The infarct size and LVEF were similar between the sexes. Elevated LVFP was observed more frequently in women than in men during the initial hospitalization and at 1 year (26% vs. 12%, p = 0.04, and 22% vs. 12%, p = 0.006, respectively). Interestingly, only initial elevated LVFP (HR 5.9, 95% CI: 2.4-14.5, p < 0.001), age, and hypertension were independently associated with rehospitalization for HF. Conclusions After PPCI-treated anterior STEMI, despite comparable infarct size and LVEF, women presented a higher proportion of rehospitalization for HF than men. That was likely due to a greater DD associated with older age and hypertension.
Collapse
Affiliation(s)
- Simon Leboube
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
| | - Louise Camboulives
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
| | - Thomas Bochaton
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
- Centre d'investigation clinique de Lyon, Hospices Civils de Lyon, Lyon, France
| | - Camille Amaz
- Centre d'investigation clinique de Lyon, Hospices Civils de Lyon, Lyon, France
| | - Cyrille Bergerot
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
| | - Mikhail Altman
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
| | - Thomas Loppinet
- Centre d'investigation clinique de Lyon, Hospices Civils de Lyon, Lyon, France
| | - Maelle Cherpaz
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
| | - Thierry Monsec
- Service de Cardiologie, Centre Hospitalier de Valence, Valence, France
| | | | - Annie Trinh
- Service de Cardiologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | | | - Anne Bernard
- Service de Cardiologie, Centre Hospitalier Universitaire de Tours, Tours, France
| | - Genevieve Derumeaux
- Service de Cardiologie, Hôpitaux Universitaires Henri Mondor, Créteil, France
| | - Nathan Mewton
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
- Centre d'investigation clinique de Lyon, Hospices Civils de Lyon, Lyon, France
| | - Michel Ovize
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
| | - Hélène Thibault
- Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Bron, France
- Laboratoire CarMeN – IRIS Team, INSERM, INRA, Université Claude Bernard Lyon-1, 21 Univ-Lyon, Bron, France
| |
Collapse
|
3
|
Boccalini S, Teulade M, Paquet E, Si-Mohamed S, Rapallo F, Moreau-Triby C, Charrière S, Mewton N, Boussel L, Bergerot C, Douek P, Moulin P. Silent myocardial infarction fatty scars detected by coronary calcium score CT scan in diabetic patients without history of coronary heart disease. Eur Radiol 2024; 34:214-225. [PMID: 37530810 DOI: 10.1007/s00330-023-09940-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 05/14/2023] [Accepted: 05/16/2023] [Indexed: 08/03/2023]
Abstract
OBJECTIVES To evaluate the prevalence of intra-myocardial fatty scars (IMFS) most likely indicating previous silent myocardial infarction (SMI), as detected on coronary artery calcium (CAC) computed tomography (CT) scans in diabetic patients without history of coronary heart disease (CHD). METHODS Diabetic patients screened for silent coronary insufficiency in a tertiary-care, university hospital between Jan-2015 and Dec-2016 were categorized according to their CAC score in two groups comprising 242 patients with CACS = 0 and 145 patients with CACS ≥ 300. CAC-CT scans were retrospectively evaluated for subendorcardial and transmural IMFS of the left ventricle. Adipose remodeling, patients' characteristics, cardiovascular risk factors and metabolic profile were compared between groups. RESULTS Eighty-three (21%) patients with IMFS were identified, 55 (37.9%) in the group CACS ≥ 300 and 28 (11.6%) in the CACS = 0 (OR = 4.67; 95% CI = 2.78-7.84; p < 0.001). Total and average surface of IMFS and their number per patient were similar in both groups (p = 0.55; p = 0.29; p = 0.61, respectively). In the group CACS ≥ 300, patients with IMFS were older (p = 0.03) and had longer-lasting diabetes (p = 0.04). Patients with IMFS were older and had longer history of diabetes, reduced glomerular filtration rate, more coronary calcifications (all p < 0.05), and higher prevalence of carotid plaques (OR = 3.03; 95% CI = 1.43-6.39, p = 0.004). After correction for other variables, only a CACS ≥ 300 (OR = 5.12; 95% CI = 2.66-9.85; p < 0.001) was associated with an increased risk of having IMFS. CONCLUSIONS In diabetic patients without known CHD, IMFSs were found in patients without coronary calcifications, although not as frequently as in patients with heavily calcified coronary arteries. It remains to be established if this marker translates in an upwards cardiovascular risk restratification especially in diabetic patients with CACS = 0. CLINICAL RELEVANCE STATEMENT In diabetic patients without history of coronary heart disease, intramyocardial fatty scars, presumably of post-infarction origin, can be detected on coronary artery calcium CT scans more frequently, but not exclusively, if the coronary arteries are heavily calcified as compared to those without calcifications. KEY POINTS • Intramyocardial fatty scars (IMFS), presumably of post-infarction origin, can be detected on coronary artery calcium (CAC) CT scans more frequently, but not exclusively, in diabetic patients with CACS ≥ 300 as compared to patients CACS = 0. • Patients with IMFS were older and had longer history of diabetes, reduced glomerular filtration rate, and more coronary calcifications. • Carotid plaques and CACS ≥ 300 were associated with an increased risk of having IMFS, about three and five folds respectively.
Collapse
Affiliation(s)
- Sara Boccalini
- Department of Cardiovascular Radiology, Hôpital Pradel, Hospices Civils de Lyon, Lyon, France.
- University Claude Bernard Lyon 1, Lyon, France.
| | - Marie Teulade
- University Claude Bernard Lyon 1, Lyon, France
- Department of Endocrinology Louis Pradel University Hospital, Hospices Civils de Lyon, INSERM UMR 1060, Carmen, Lyon, France
| | - Emilie Paquet
- Department of Nuclear Medicine, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France
| | - Salim Si-Mohamed
- Department of Cardiovascular Radiology, Hôpital Pradel, Hospices Civils de Lyon, Lyon, France
- University Claude Bernard Lyon 1, Lyon, France
| | - Fabio Rapallo
- Department of Economics, University of Genova, Genoa, Italy
| | - Caroline Moreau-Triby
- Department of Nuclear Medicine, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France
| | - Sybil Charrière
- University Claude Bernard Lyon 1, Lyon, France
- Department of Endocrinology Louis Pradel University Hospital, Hospices Civils de Lyon, INSERM UMR 1060, Carmen, Lyon, France
| | - Nathan Mewton
- University Claude Bernard Lyon 1, Lyon, France
- Department of Cardiology, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France
| | - Loic Boussel
- Department of Radiology, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
| | - Cyrille Bergerot
- Department of Cardiology, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France
| | - Philippe Douek
- Department of Cardiovascular Radiology, Hôpital Pradel, Hospices Civils de Lyon, Lyon, France
- University Claude Bernard Lyon 1, Lyon, France
| | - Philippe Moulin
- University Claude Bernard Lyon 1, Lyon, France
- Department of Endocrinology Louis Pradel University Hospital, Hospices Civils de Lyon, INSERM UMR 1060, Carmen, Lyon, France
| |
Collapse
|
4
|
Jacquin L, Battault M, Mewton N, Mantout A, Bergerot C, Tazarourte K, Douplat M. Outcome of patients admitted with oxygen mismatch and myocardial injury or infarction in emergency departments. J Cardiovasc Med (Hagerstown) 2023; 24:159-166. [PMID: 36753723 DOI: 10.2459/jcm.0000000000001443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
AIMS To describe the outcomes and associated factors in a population of patients admitted to emergency departments with at least one condition of oxygen supply/demand imbalance, regardless of the troponin result or restrictive criteria for type 2 myocardial infarction. METHODS We constituted a retrospective cohort of 824 patients. Medical records of patients having undergone a troponin assay were reviewed for selection and classification, and data including in-hospital stay and readmissions were collected. The reported outcomes are in-hospital mortality, 3-year mortality, and major adverse cardiovascular events. RESULTS Patients with myocardial infarction or injury, either chronic or acute, were older, with more history of hypertension and chronic heart or renal failure but not for other cardiovascular risk factors and medical history. Acute myocardial injury and type 2 myocardial infarction were significantly associated with in-hospital mortality [odds ratio (OR) 3.71 95% confidence interval (CI) 1.90-7.33 and OR 3.15 95% CI 1.59-6.28, respectively]. However, the long-term mortality does not differ in comparison with patients presenting chronic myocardial injury or nonelevated troponin, ranging from 26.9 to 34.3%. Patients with chronic myocardial injury and type 2 myocardial infarction had more long-term major cardiovascular events (39.3 and 38.8%), but only for acute heart failure, and none was associated with this outcome after adjustment. CONCLUSION Among patients admitted to emergency departments with an oxygen supply/demand imbalance, acute myocardial injury and type 2 myocardial infarction are strongly associated with in-hospital mortality. However, they are not associated with higher long-term mortality or major cardiovascular events after discharge, which tend to occur in elderly people with comorbidities.
Collapse
Affiliation(s)
- Laurent Jacquin
- Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'accueil des urgence.,Université Lyon-1, CarMeN Team 3 Ischemia-Reperfusion Syndromes (IRIS), INSERM UMR 1060
| | - Marion Battault
- Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'accueil des urgence
| | - Nathan Mewton
- Université Lyon-1, CarMeN Team 3 Ischemia-Reperfusion Syndromes (IRIS), INSERM UMR 1060.,Hospices Civils de Lyon, Hôpital Louis Pradel, Centre d'investigation clinique, INSERM 1407, Lyon.,Hospices Civils de Lyon, Hôpital Louis Pradel, Service de cardiologie, Bron
| | - Adrien Mantout
- Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'accueil des urgences, Pierre Bénite
| | - Cyrille Bergerot
- Hospices Civils de Lyon, Hôpital Louis Pradel, Centre d'investigation clinique, INSERM 1407, Lyon.,Hospices Civils de Lyon, Hôpital Louis Pradel, Service de cardiologie, Bron
| | - Karim Tazarourte
- Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'accueil des urgence.,Université Lyon-1, Laboratoire Health Services and Performance Research (HESPER) EA 7425, Lyon, France
| | - Marion Douplat
- Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'accueil des urgences, Pierre Bénite.,Université Lyon-1, Laboratoire Health Services and Performance Research (HESPER) EA 7425, Lyon, France
| |
Collapse
|
5
|
Boccalini S, Si-Mohamed SA, Lacombe H, Diaw A, Varasteh M, Rodesch PA, Villien M, Sigovan M, Dessouky R, Coulon P, Yagil Y, Lahoud E, Erhard K, Rioufol G, Finet G, Bonnefoy-Cudraz E, Bergerot C, Boussel L, Douek PC. First In-Human Results of Computed Tomography Angiography for Coronary Stent Assessment With a Spectral Photon Counting Computed Tomography. Invest Radiol 2022; 57:212-221. [PMID: 34711766 PMCID: PMC8903215 DOI: 10.1097/rli.0000000000000835] [Citation(s) in RCA: 54] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Accepted: 08/18/2021] [Indexed: 11/26/2022]
Abstract
OBJECTIVES The aim of this study is to compare the image quality of in vivo coronary stents between an energy integrating detectors dual-layer computed tomography (EID-DLCT) and a clinical prototype of spectral photon counting computed tomography (SPCCT). MATERIALS AND METHODS In January to June 2021, consecutive patients with coronary stents were prospectively enrolled to undergo a coronary computed tomography (CT) with an EID-DLCT (IQon, Philips) and an SPCCT (Philips). The study was approved by the local ethical committee and patients signed an informed consent. A retrospectively electrocardiogram-gated acquisition was performed with optimized matching parameters on the 2 scanners (EID-DLCT: collimation, 64 × 0.625 mm; kVp, 120, automatic exposure control with target current at 255 mAs; rotation time, 0.27 seconds; SPCCT: collimation, 64 × 0.275 mm; kVp, 120; mAs, 255; rotation time, 0.33 seconds). The injection protocol was the same on both scanners: 65 to 75 mL of Iomeron (Bracco) at 5 mL/s. Images were reconstructed with slice thickness of 0.67 mm, 512 matrix, XCB (Xres cardiac standard) and XCD (Xres cardiac detailed) kernel, iDose 3 for EID-DLCT and 0.25-mm slice thickness, 1024 matrix, Detailed 2 and Sharp kernel, and iDose 6 for SPCCT. Two experienced observers measured the proximal and distal external and internal diameters of the stents to quantify blooming artifacts. Regions of interest were drawn in the lumen of the stent and of the upstream coronary artery. The difference (Δ S-C) between the respective attenuation values was calculated as a quantification of stent-induced artifacts on intrastent image quality. For subjective image quality, 3 experienced observers graded with a 4-point scale the image quality of different parameters: coronary wall before the stent, stent lumen, stent structure, calcifications surrounding the stent, and beam-hardening artifacts. RESULTS Eight patients (age, 68 years [interquartile range, 8]; all men; body mass index, 26.2 kg/m2 [interquartile range, 4.2]) with 16 stents were scanned. Five stents were not evaluable owing to motion artifacts on the SPCCT. Of the remaining, all were drug eluting stents, of which 6 were platinum-chromium, 3 were cobalt-platinum-iridium, and 1 was stainless steel. For 1 stent, no information could be retrieved. Radiation dose was lower with the SPCCT (fixed CT dose index of 25.7 mGy for SPCCT vs median CT dose index of 35.7 [IQ = 13.6] mGy; P = 0.02). For 1 stent, the internal diameter was not assessable on EID-DLCT. External diameters were smaller and internal diameters were larger with SPCCT (all P < 0.05). Consequently, blooming artifacts were reduced on SPCCT (P < 0.05). Whereas Hounsfield unit values within the coronary arteries on the 2 scanners were similar, the Δ S-C was lower for SPCCT-Sharp as compared with EID-DLCT-XCD and SPCCT-Detailed 2 (P < 0.05). The SPCCT received higher subjective scores than EID-DLCT for stent lumen, stent structure, surrounding calcifications and beam-hardening for both Detailed 2 and Sharp (all P ≤ 0.05). The SPCCT-Sharp was judged better for stent structure and beam-hardening assessment as compared with SPCCT-Detailed 2. CONCLUSION Spectral photon counting CT demonstrated improved objective and subjective image quality as compared with EID-DLCT for the evaluation of coronary stents even with a reduced radiation dose.
Collapse
Affiliation(s)
- Sara Boccalini
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
- Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Salim A. Si-Mohamed
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
- Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Hugo Lacombe
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
| | - Adja Diaw
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
| | - Mohammad Varasteh
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
| | - Pierre-Antoine Rodesch
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
| | | | - Monica Sigovan
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
| | - Riham Dessouky
- Department of Radiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
| | | | | | | | | | - Gilles Rioufol
- Department of Cardiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Gerard Finet
- Department of Cardiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Eric Bonnefoy-Cudraz
- Department of Cardiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Cyrille Bergerot
- Department of Cardiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Loic Boussel
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
- Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Philippe C. Douek
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, France
- Department of Cardiovascular and Thoracic Radiology, Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| |
Collapse
|
6
|
Si-Mohamed SA, Boccalini S, Lacombe H, Diaw A, Varasteh M, Rodesch PA, Dessouky R, Villien M, Tatard-Leitman V, Bochaton T, Coulon P, Yagil Y, Lahoud E, Erhard K, Riche B, Bonnefoy E, Rioufol G, Finet G, Bergerot C, Boussel L, Greffier J, Douek PC. Coronary CT Angiography with Photon-counting CT: First-In-Human Results. Radiology 2022; 303:303-313. [PMID: 35166583 DOI: 10.1148/radiol.211780] [Citation(s) in RCA: 109] [Impact Index Per Article: 54.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Background Spatial resolution, soft-tissue contrast, and dose-efficient capabilities of photon-counting CT (PCCT) potentially allow a better quality and diagnostic confidence of coronary CT angiography (CCTA) in comparison to conventional CT. Purpose To compare the quality of CCTA scans obtained with a clinical prototype PCCT system and an energy-integrating detector (EID) dual-layer CT (DLCT) system. Materials and Methods In this prospective board-approved study with informed consent, participants with coronary artery disease underwent retrospective electrocardiographically gated CCTA with both systems after injection of 65-75 mL of 400 mg/mL iodinated contrast agent at 5 mL/sec. A prior phantom task-based quality assessment of the detectability index of coronary lesions was performed. Ultra-high-resolution parameters were used for PCCT (1024 matrix, 0.25-mm section thickness) and EID DLCT (512 matrix, 0.67-mm section thickness). Three cardiac radiologists independently performed a blinded analysis using a five-point quality score (1 = insufficient, 5 = excellent) for overall image quality, diagnostic confidence, and diagnostic quality of calcifications, stents, and noncalcified plaques. A logistic regression model, adjusted for radiologists, was used to evaluate the proportion of improvement in scores with the best method. Results Fourteen consecutive participants (12 men; mean age, 61 years ± 17) were enrolled. Scores of overall quality and diagnostic confidence were higher with PCCT images with a median of 5 (interquartile range [IQR], 2) and 5 (IQR, 1) versus 4 (IQR, 1) and 4 (IQR, 3) with EID DLCT images, using a mean tube current of 255 mAs ± 0 versus 349 mAs ± 111 for EID DLCT images (P < .01). Proportions of improvement with PCCT images for quality of calcification, stent, and noncalcified plaque were 100%, 92% (95% CI: 71, 98), and 45% (95% CI: 28, 63), respectively. In the phantom study, detectability indexes were 2.3-fold higher for lumen and 2.9-fold higher for noncalcified plaques with PCCT images. Conclusion Coronary CT angiography with a photon-counting CT system demonstrated in humans an improved image quality and diagnostic confidence compared with an energy-integrating dual-layer CT. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Sandfort and Bluemke in this issue.
Collapse
Affiliation(s)
- Salim A Si-Mohamed
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Sara Boccalini
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Hugo Lacombe
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Adja Diaw
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Mohammad Varasteh
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Pierre-Antoine Rodesch
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Riham Dessouky
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Marjorie Villien
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Valérie Tatard-Leitman
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Thomas Bochaton
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Philippe Coulon
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Yoad Yagil
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Elias Lahoud
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Klaus Erhard
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Benjamin Riche
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Eric Bonnefoy
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Gilles Rioufol
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Gerard Finet
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Cyrille Bergerot
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Loic Boussel
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Joel Greffier
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| | - Philippe C Douek
- From the University Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Villeurbanne, France (S.A.S.M., S.B., H.L., A.D., M. Varasteh, P.A.R., V.T.L., L.B., P.C.D.); Departments of Radiology (S.A.S.M., S.B., L.B., P.C.D.) and Cardiology (T.B., E.B., G.R., G.F., C.B.), Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France; Department of Radiology, Faculty of Medicine, Zagazig University, Egypt (R.D.); Philips Healthcare, Suresnes, France (M Villien, P.C.); Philips Healthcare, Haifa, Israel (Y.Y., E.L.); Philips Healthcare, Hamburg, Germany (K.E.); Public Health Center, Department of Biostatistics and Bioinformatics, Hospices Civils de Lyon, Lyon, France (B.R.); Department of Biometrics and Evolutionary Biology Laboratory, Biostatistics-Health Team, CNRS, UMR 5558, Villeurbanne, France (B.R.); and Department of Medical Imaging, CHU Nimes, University Montpellier, Nimes Medical Imaging Group, EA 2992, Montpellier, France (J.G.)
| |
Collapse
|
7
|
Cambet T, Bochaton T, Bel F, Derimay F, Varillon Y, Amaz C, Bonnefoy-Cudraz E, Angoulvant D, Charriere S, Moulin P, Mewton N, Bergerot C. Lipid goal achievements after acute myocardial infarction: the gap between real-life and ESC 2019 guidelines. Eur J Prev Cardiol 2021; 29:e65-e67. [PMID: 33615341 DOI: 10.1093/eurjpc/zwaa160] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2020] [Revised: 12/08/2020] [Accepted: 12/14/2020] [Indexed: 12/24/2022]
Affiliation(s)
- Théo Cambet
- Service des explorations fonctionnelles cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677Bron Cedex, France
| | - Thomas Bochaton
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Unité de Soins Intensifs Cardiologiques, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Floriane Bel
- Département de Pharmacie, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - François Derimay
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Department of Interventional Cardiology, Cardiovascular Hospital and INSERM Unit 1060 CARMEN, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Yvonne Varillon
- Centre d'Investigation Clinique de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Camille Amaz
- Centre d'Investigation Clinique de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Eric Bonnefoy-Cudraz
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Unité de Soins Intensifs Cardiologiques, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Denis Angoulvant
- Cardiology Department and EA4245 T2i, Faculté de Médecine, Tours University Hospital, Tours University, F-37000 Tours, France
| | - Sybil Charriere
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Hospices Civils de Lyon, Hôpital Louis Pradel, Fédération d'Endocrinologie, Maladies métaboliques, Diabète et Nutrition, Groupement Hospitalier Est, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Philippe Moulin
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Hospices Civils de Lyon, Hôpital Louis Pradel, Fédération d'Endocrinologie, Maladies métaboliques, Diabète et Nutrition, Groupement Hospitalier Est, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Nathan Mewton
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Centre d'Investigation Clinique de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| | - Cyrille Bergerot
- Service des explorations fonctionnelles cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677Bron Cedex, France.,Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, INSERM UMR 1060 Carmen, Université Claude Bernard Lyon 1, 28 avenue Doyen Lépine, 69677 Bron Cedex, France.,Centre d'Investigation Clinique de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 28 avenue Doyen Lépine, 69677 Bron Cedex, France
| |
Collapse
|
8
|
Bergerot C, Angoulvant D, Lemesle G, Barone-Rochette G, Mewton N, Mach F. It's never too early to beat your low-density lipoprotein cholesterol. Arch Cardiovasc Dis 2021; 114:1-3. [PMID: 33509745 DOI: 10.1016/j.acvd.2021.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 01/06/2021] [Accepted: 01/07/2021] [Indexed: 11/19/2022]
Affiliation(s)
- Cyrille Bergerot
- Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France; Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Inserm UMR 1060 CarMeN, Université Claude Bernard Lyon 1, 69500 Bron, France.
| | - Denis Angoulvant
- Cardiology Department and EA4245 T2i, Faculté de Médecine, Tours University Hospital, Tours University, 37000 Tours, France
| | - Gilles Lemesle
- Institut Coeur Poumon, Centre Hospitalier Universitaire de Lille, 59000 Lille; Université de Lille, 59000 Lille; Institut Pasteur de Lille, Inserm U1011, 59000 Lille; FACT (French Alliance for Cardiovascular Trials), 75000 Paris, France
| | - Gilles Barone-Rochette
- Department of Cardiology, University Hospital Grenoble-Alpes, 38700 La Tronche; Inserm U1039, Bioclinic Radiopharmaceutics Laboratory, 38700 Grenoble, La Tronche; French Clinical Research Infrastructure Network, 31059 Toulouse, France
| | - Nathan Mewton
- Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Inserm UMR 1060 CarMeN, Université Claude Bernard Lyon 1, 69500 Bron, France; Centre d'Investigation Clinique de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France
| | - François Mach
- Cardiology Division, Department of Specialties in Medicine, Geneva University Hospitals, 1211 Geneva 14, Switzerland
| |
Collapse
|
9
|
Pezel T, Besseyre Des Horts T, Schaaf M, Croisille P, Biere L, Garcia Dorado D, Jossan C, Roubille F, Tri Cung T, Prunier F, Elbaz M, Amaz C, Derumeaux G, De Poli F, Hovassse T, Gilard M, Bergerot C, Thibault H, Ovize M, Mewton N. Predictive value of early cardiac mri functional and geometric indexes on adverse left ventricular remodelling in anterior STEMI patients. A report from the CIRCUS study. Archives of Cardiovascular Diseases Supplements 2021. [DOI: 10.1016/j.acvdsp.2020.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
10
|
Pezel T, Besseyre des Horts T, Schaaf M, Croisille P, Bière L, Garcia-Dorado D, Jossan C, Roubille F, Cung TT, Prunier F, Meyer E, Amaz C, Derumeaux G, de Poli F, Hovasse T, Gilard M, Bergerot C, Thibault H, Ovize M, Mewton N. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study. Arch Cardiovasc Dis 2020; 113:710-720. [PMID: 33160891 DOI: 10.1016/j.acvd.2020.05.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 04/17/2020] [Accepted: 05/13/2020] [Indexed: 11/25/2022]
Abstract
BACKGROUND Postinfarction adverse left ventricular (LV) remodelling is strongly associated with heart failure events. Conicity index, sphericity index and LV global functional index (LVGFI) are new LV remodelling indexes assessed by cardiac magnetic resonance (CMR). AIM To assess the predictive value of the new indexes for 1-year adverse LV remodelling in patients with anterior ST-segment elevated myocardial infarction (STEMI). METHODS CMR studies were performed in 129 patients with anterior STEMI (58±12 years; 78% men) from the randomized CIRCUS trial (CMR substudy) treated with primary percutaneous coronary intervention and followed for the occurrence of major adverse cardiovascular events (MACE) (death or hospitalization for heart failure). Conicity index, sphericity index, LVGFI, infarct size and microvascular obstruction (MVO) were assessed by CMR performed 5±4 days after coronary reperfusion. Adverse LV remodelling was defined as an increase in LV end-diastolic volume of ≥15% by transthoracic echocardiography at 1 year. RESULTS Adverse LV remodelling occurred in 27% of patients at 1 year. Infarct size and MVO were significantly predictive of adverse LV remodelling: odds ratio [OR] 1.03, 95% confidence interval [CI] 1.01-1.05 (P<0.001) and OR 1.12, 95% CI 1.05-1.22 (P<0.001), respectively. Among the newly tested indexes, only LVGFI was significantly predictive of adverse LV remodelling (OR 1.10, 95% CI 1.03-1.16; P=0.001). In multivariable analysis, infarct size remained an independent predictor of adverse LV remodelling at 1 year (OR 1.05, 95% CI 1.02-1.08; P<0.001). LVGFI and infarct size were associated with occurrence of MACE: OR 1.21, 95% CI 1.08-1.37 (P<0.001) and OR 1.02, 95% CI 1.00-1.04 (P=0.018), respectively. Conicity and sphericity indexes were not associated with MACE. CONCLUSIONS LVGFI was associated with adverse LV remodelling and MACE 1 year after anterior STEMI.
Collapse
Affiliation(s)
- Théo Pezel
- Inserm, UMRS 942, Department of Cardiology, Lariboisière Hospital, Paris University, AP-HP, 75010 Paris, France; Division of Cardiology, Johns-Hopkins University, 21287-0409 Baltimore, MD, USA
| | - Timothée Besseyre des Horts
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Mathieu Schaaf
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Pierre Croisille
- Radiology Department, University Hospital of Saint-Étienne, 42270 Saint-Priest-en-Jarez, France
| | - Loïc Bière
- Cardiology Division, University Hospital of Angers, 49100 Angers, France
| | - David Garcia-Dorado
- CIBERCV, Hospital Universitari Vall d'Hebron & Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
| | - Claire Jossan
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - François Roubille
- UMR5203, UMR661, Cardiology Division, University Hospital of Montpellier, University of Montpellier 1 and 2, 34295 Montpellier, France
| | - Thien-Tri Cung
- UMR5203, UMR661, Cardiology Division, University Hospital of Montpellier, University of Montpellier 1 and 2, 34295 Montpellier, France
| | - Fabrice Prunier
- Cardiology Division, University Hospital of Angers, 49100 Angers, France
| | - Elbaz Meyer
- Rangeuil Hospital, University Hospital of Toulouse, Paul-Sabatier University, 31400 Toulouse, France
| | - Camille Amaz
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Geneviève Derumeaux
- DHU-ATVB, Henri-Mondor Hospital, Paris-Est Créteil University, AP-HP, 94010 Créteil, France
| | - Fabien de Poli
- Cardiology Division, Haguenau Hospital, 67500 Haguenau, France
| | - Thomas Hovasse
- Cardiology Division, Jacques-Cartier Institute, 91300 Massy, France
| | - Martine Gilard
- Department of Cardiology, Brest University Hospital, 29200 Brest, France
| | - Cyrille Bergerot
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Hélène Thibault
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Michel Ovize
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France
| | - Nathan Mewton
- Inserm 1407, Clinical Investigation Centre and Heart Failure Department, Cardiovascular Hospital Louis-Pradel, hospices civils de Lyon, université Claude-Bernard Lyon 1, 69677 Bron, France.
| |
Collapse
|
11
|
Schiele F, Lemesle G, Angoulvant D, Krempf M, Kownator S, Cheggour S, Belle L, Ferrières J, Bauters C, Bergerot C, Beygui F, Boccara F, Bonnefoy E, Bruckert E, Cayla G, Collet JP, Coste P, Descotes-Genon V, Ducrocq G, Elbaz M, Farnier M, Ferrari E, Guedj D, Levai L, Mansourati J, Mansencal N, Meneveau N, Meune C, Morel O, Ohlmann P, Paillard F, Piot C, Puymirat E, Rioufol G, Roubille F, Sabouret P, Teiger E. Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction. European Heart Journal. Acute Cardiovascular Care 2020; 9:788-801. [DOI: 10.1177/2048872619844444] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Abstract
In patients admitted for acute myocardial infarction, the communication and transition from specialists to primary care physicians is often delayed, and the information imparted to subsequent healthcare providers (HCPs) may be sub-optimal. A French group of cardiologists, lipidologists and diabetologists decided to establish a consensus to optimize the discharge letter after hospitalization for acute myocardial infarction. The aim is to improve both the timeframe and the quality of the content transmitted to subsequent HCPs, including information regarding baseline assessment, procedures during hospitalization, residual risk, discharge treatments, therapeutic targets and follow-up recommendations in compliance with European Society of Cardiology guidelines. A consensus was obtained regarding a template discharge letter, to be released within two days after patient’s discharge, and containing the description of the patient’s history, risk factors, acute management, risk assessment, discharge treatments and follow-up pathway. Specifically for post acute MI patients, tailored details are necessary regarding the antithrombotic regimen, lipid-lowering and anti-diabetic treatments, including therapeutic targets. Lastly, the follow-up pathway needs to be precisely mentioned in the discharge letter. Additional information such as technical descriptions, imaging, and quality indicators may be provided separately. A template for a standardized discharge letter based on 8 major headings could be useful for implementation in routine practice and help to improve the quality and timing of information transmission between HCPs after acute MI.
Collapse
Affiliation(s)
- Francois Schiele
- Department of Cardiology, University Hospital Besancon, and EA3920, University of Franche-Comté, Besancon, France
| | - Gilles Lemesle
- USIC et Centre Hémodynamique, Institut Cœur Poumon, Centre Hospitalier Universitaire de Lille, France
- Faculté de Médecine de l’Université de Lille, France
- INSERM UMR 1011, Institut Pasteur de Lille, France
- FACT (French Alliance for Cardiovascular Trials), Paris, France
| | - Denis Angoulvant
- Service de cardiologie, faculté de médecine, université François-Rabelais, CHU Trousseau, Tours
| | - Michel Krempf
- CHU de Nantes-Hôpital Nord Laennec, Saint Herblain, France
| | | | | | - Loic Belle
- Service de Cardiologie, Centre Hospitalier Annecy-Genevois, Metz-Tessy, France
| | - Jean Ferrières
- Service de Cardiologie B, CHU Rangueil, Toulouse, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Cambet T, Amaz C, Bel F, Ovize M, Varillon Y, Bochaton T, Mewton N, Bergerot C. LDL cholesterol reduction by lipid lowering therapy after acute myocardial infarction is not significantly influenced by baseline systemic inflammation. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2020.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
13
|
Rabia M, Leuzy V, Soulage C, Durand A, Fourmaux B, Errazuriz-Cerda E, Köffel R, Draeger A, Colosetti P, Jalabert A, Di Filippo M, Villard-Garon A, Bergerot C, Luquain-Costaz C, Moulin P, Rome S, Delton I, Hullin-Matsuda F. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles. Biochimie 2020; 178:26-38. [PMID: 32659447 DOI: 10.1016/j.biochi.2020.07.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 06/29/2020] [Accepted: 07/08/2020] [Indexed: 01/05/2023]
Abstract
Bis(monoacylglycero)phosphate (BMP), also known as lysobisphosphatidic acid (LBPA), is a phospholipid specifically enriched in the late endosome-lysosome compartment playing a crucial role for the fate of endocytosed components. Due to its presence in extracellular fluids during diseases associated with endolysosomal dysfunction, it is considered as a possible biomarker of disorders such as genetic lysosomal storage diseases and cationic amphiphilic drug-induced phospholipidosis. However, there is no true validation of this biomarker in human studies, nor a clear identification of the carrier of this endolysosome-specific lipid in biofluids. The present study demonstrates that in absence of any sign of renal failure, BMP, especially all docosahexaenoyl containing species, are significantly increased in the urine of patients treated with the antiarrhythmic drug amiodarone. Such urinary BMP increase could reflect a generalized drug-induced perturbation of the endolysosome compartment as observed in vitro with amiodarone-treated human macrophages. Noteworthy, BMP was associated with extracellular vesicles (EVs) isolated from human urines and extracellular medium of human embryonic kidney HEK293 cells and co-localizing with classical EV protein markers CD63 and ALIX. In the context of drug-induced endolysosomal dysfunction, increased BMP-rich EV release could be useful to remove excess of undigested material. This first human pilot study not only reveals BMP as a urinary biomarker of amiodarone-induced endolysosomal dysfunction, but also highlights its utility to prove the endosomal origin of EVs, also named as exosomes. This peculiar lipid already known as a canonical late endosome-lysosome marker, may be thus considered as a new lipid marker of urinary exosomes.
Collapse
Affiliation(s)
- Maxence Rabia
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Valentin Leuzy
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Christophe Soulage
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Annie Durand
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Baptiste Fourmaux
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Functional Lipidomics Platform, CarMeN Laboratory / IMBL-INSA Lyon, 69621, Villeurbanne Cedex, France
| | | | - René Köffel
- Department of Cell Biology, Institute of Anatomy, University of Bern, Bern, Switzerland
| | - Annette Draeger
- Department of Cell Biology, Institute of Anatomy, University of Bern, Bern, Switzerland
| | - Pascal Colosetti
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Audrey Jalabert
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Mathilde Di Filippo
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Department of Biochemistry and Molecular Biology, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France
| | - Audrey Villard-Garon
- Department of Endocrinology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Cyrille Bergerot
- Department of Cardiology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Céline Luquain-Costaz
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Philippe Moulin
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Department of Endocrinology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Sophie Rome
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Isabelle Delton
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | | |
Collapse
|
14
|
Bochaton T, Claeys MJ, Garcia-Dorado D, Mewton N, Bergerot C, Jossan C, Amaz C, Boussaha I, Thibault H, Ovize M. Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients. Basic Res Cardiol 2019; 115:4. [PMID: 31832789 DOI: 10.1007/s00395-019-0764-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Accepted: 11/21/2019] [Indexed: 12/16/2022]
Abstract
Despite promising experimental studies and encouraging proof-of-concept clinical trials, interventions aimed at limiting infarct size have failed to improve clinical outcomes in patients with ST-elevation myocardial infarction (STEMI). Our objective was to examine whether variables (cardiovascular risk factors, comorbidities, post-procedural variables, cotreatments) might be associated with clinical outcomes in STEMI patients independently from infarct size reduction. The present study was based on a post hoc analysis of the CIRCUS trial database (Clinicaltrials.gov NCT01502774) that assessed the clinical benefit of a single intravenous bolus of cyclosporine in 969 patients with anterior STEMI. Since cyclosporine had no detectable effect on clinical outcomes as well as on any measured variable, we here considered the whole study population as one group. Multivariate analysis was performed to address the respective weight of infarct size and variables in clinical outcomes. Multivariate analysis revealed that several variables (including gender, hypertension, renal dysfunction, TIMI flow grade post-PCI < 3, and treatment administered after PCI with betablockers and angiotensin-converting enzyme inhibitors) had per se a significant influence on the occurrence of [death or hospitalization for heart failure] at 1 year. The relative weight of infarct size and variables on the composite endpoint of [death or hospitalization for heart failure] at 1 year was 18% and 82%, respectively. Several variables contribute strongly to the clinical outcomes of STEMI patients suggesting that cardioprotective strategy might not only focus on infarct size reduction.
Collapse
Affiliation(s)
- Thomas Bochaton
- INSERM UMR 1060, CarMeN Laboratory, University Claude Bernard Lyon1, IHU OPeRa, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Marc J Claeys
- Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium
| | - David Garcia-Dorado
- Hospital Universitari Vall d´Hebron, Department of Cardiology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en Red-CV, Barcelona, Spain
| | - Nathan Mewton
- INSERM UMR 1060, CarMeN Laboratory, University Claude Bernard Lyon1, IHU OPeRa, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Cyrille Bergerot
- INSERM UMR 1060, CarMeN Laboratory, University Claude Bernard Lyon1, IHU OPeRa, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France.,Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Claire Jossan
- Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Camille Amaz
- Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Inesse Boussaha
- Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Hélène Thibault
- INSERM UMR 1060, CarMeN Laboratory, University Claude Bernard Lyon1, IHU OPeRa, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France.,Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France
| | - Michel Ovize
- INSERM UMR 1060, CarMeN Laboratory, University Claude Bernard Lyon1, IHU OPeRa, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France. .,Service d'Explorations Fonctionnelles Cardiovasculaires CIC 1407 de Lyon, Hôpital Louis Pradel, Hospices Civils de Lyon, 69677, Lyon, France. .,Service d'Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, 59 Bd Pinel, 69394, Bron, France.
| |
Collapse
|
15
|
Bergerot C, Chauveau S, Py A, Berges AS, Nighoghossian N, Ovize M, Maucort-Boulch D, Chevalier P, Mechtouff L, Thibault H. P6383Use of routine E/A ratio echocardiographic following cerebral ischemia is associated with paroxysmal atrial fibrillation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C Bergerot
- Research Laboratory CarMEN of Lyon, Centre d'Investigation Clinique, Lyon, France
| | - S Chauveau
- Civils Hospices of Lyon, (2) Department of Rhythmology Groupement Hospitalier Est, Hospices Civils de Lyon, 28 Avenue Doyen L, Lyon, France
| | - A Py
- Research Laboratory CarMEN of Lyon, Centre d'Investigation Clinique, Lyon, France
| | - A S Berges
- Civils Hospices of Lyon, (3) UHIM Groupement Hospitalier Est, Hospices Civils de Lyon, 28 Avenue Doyen Lépine, Bron 69677, Fr, Lyon, France
| | - N Nighoghossian
- Civils Hospices of Lyon, (4) Stroke Unit, Groupement Hospitalier Est, Hospices Civiles de Lyon, Lyon, France, Lyon, France
| | - M Ovize
- Research Laboratory CarMEN of Lyon, Centre d'Investigation Clinique, Lyon, France
| | - D Maucort-Boulch
- Civils Hospices of Lyon, (6) Hospices Civils de Lyon, Service de Biostatistique et Bioinformatique, F-69003 Lyon, Lyon, France
| | - P Chevalier
- Civils Hospices of Lyon, (2) Department of Rhythmology Groupement Hospitalier Est, Hospices Civils de Lyon, 28 Avenue Doyen L, Lyon, France
| | - L Mechtouff
- Civils Hospices of Lyon, (4) Stroke Unit, Groupement Hospitalier Est, Hospices Civiles de Lyon, Lyon, France, Lyon, France
| | - H Thibault
- Research Laboratory CarMEN of Lyon, Centre d'Investigation Clinique, Lyon, France
| |
Collapse
|
16
|
Verdugo Marchese M, Thibault H, Bergerot C, Besseyre T, Thivolet S, Jossan C, Mewton N, Ovize M. P6491Early echocardiography predictors of cardiopulmonary exercise performance after STEMI. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Verdugo Marchese
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - H Thibault
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Bergerot
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - T Besseyre
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - S Thivolet
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Jossan
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - N Mewton
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - M Ovize
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| |
Collapse
|
17
|
Camboulives L, Amaz C, Besseyre-Des-Horts T, Bergerot C, Monsec T, Altman M, Mewton N, Ovize M, Thibault H. P4602Women have a different cardiac phenotype after reperfused STEMI compared to men. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- L Camboulives
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| | - C Amaz
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | | | - C Bergerot
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| | - T Monsec
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| | - M Altman
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| | - N Mewton
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - M Ovize
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| | - H Thibault
- University Hospital of Lyon - Hospital Louis Pradel, Lyon, France
| |
Collapse
|
18
|
Verdugo Marchese M, Thibault H, Bergerot C, Besseyre T, Deframont Y, Pichot S, Jossan C, Mewton N, Ovize M. P6498What are the determinants of diastolic dysfunction after reperfused STEMI? Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M Verdugo Marchese
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - H Thibault
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Bergerot
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - T Besseyre
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - Y Deframont
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - S Pichot
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Jossan
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - N Mewton
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - M Ovize
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| |
Collapse
|
19
|
Verdugo Marchese M, Thibault H, Bergerot C, Besseyre T, Barthelet M, Jossan C, Mewton N, Ovize M. P3724Is acute myocardial segmental longitudinal strain accurate enough to predict functional recovery one month after acute STEMI? Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Verdugo Marchese
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - H Thibault
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Bergerot
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - T Besseyre
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - M Barthelet
- Lyon University Hospital, Service d'Explorations Fonctionnelles Cardiovasculaires, Lyon, France
| | - C Jossan
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - N Mewton
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| | - M Ovize
- Civils Hospices of Lyon, Centre d'Investigation Clinique de Lyon, Lyon, France
| |
Collapse
|
20
|
Mewton N, Bergerot C, Cornu C. Letter by Mewton et al Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK". Circulation 2018; 137:1759-1760. [PMID: 29661961 DOI: 10.1161/circulationaha.117.032045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Nathan Mewton
- Clinical Investigation Center, Cardiovascular Hospital Louis Pradel, Inserm 1407, Lyon, France (N.W., C.B., C.C.).,Cardiology Department, Cardiovascular Hospital Louis Pradel, Hospices Civils de Lyon, Lyon, France (N.W., C.B.)
| | - Cyrille Bergerot
- Clinical Investigation Center, Cardiovascular Hospital Louis Pradel, Inserm 1407, Lyon, France (N.W., C.B., C.C.).,Cardiology Department, Cardiovascular Hospital Louis Pradel, Hospices Civils de Lyon, Lyon, France (N.W., C.B.)
| | - Catherine Cornu
- Clinical Investigation Center, Cardiovascular Hospital Louis Pradel, Inserm 1407, Lyon, France (N.W., C.B., C.C.)
| |
Collapse
|
21
|
Bergerot C, Py A, Chauveau S, Mechtouff L, Maucort-Boulch D, Nighoghossian N, Ovize M, Thibault H. Transmitral inflow pattern predicts occult paroxysmal atrial fibrillation in the acute phase of ischemic stroke or transient ischemic attack. Archives of Cardiovascular Diseases Supplements 2018. [DOI: 10.1016/j.acvdsp.2018.02.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
22
|
Ernande L, Audureau E, Jellis CL, Bergerot C, Henegar C, Sawaki D, Czibik G, Volpi C, Canoui-Poitrine F, Thibault H, Ternacle J, Moulin P, Marwick TH, Derumeaux G. Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus. J Am Coll Cardiol 2017; 70:1704-1716. [PMID: 28958326 DOI: 10.1016/j.jacc.2017.07.792] [Citation(s) in RCA: 83] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Accepted: 07/31/2017] [Indexed: 01/17/2023]
Abstract
BACKGROUND Type 2 diabetes mellitus (T2DM) may alter cardiac structure and function, but obesity, hypertension (HTN), or aging can induce similar abnormalities. OBJECTIVES This study sought to link cardiac phenotypes in T2DM patients with clinical profiles and outcomes using cluster analysis. METHODS Baseline echocardiography and a composite endpoint (cardiovascular mortality and hospitalization) were evaluated in 842 T2DM patients from 2 prospective cohorts. A cluster analysis was performed on echocardiographic variables, and the association between clusters and clinical profiles and outcomes was assessed. RESULTS Three clusters were identified. Cluster 1 patients had the lowest left ventricular (LV) mass index and ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e') ratio, had the highest left ventricular ejection fraction (LVEF), and were predominantly male with the lowest rate of obesity or HTN. Cluster 2 patients had the highest strain and highest E/e' ratio, were the oldest, were predominantly female, and had the lowest rate of isolated T2DM (without HTN or obesity). Cluster 3 patients had the highest LV mass index and volumes and the lowest LVEF and strain, were predominantly male, and shared similar age and rate of obesity and HTN as cluster 1 patients. After follow-up of 67 months (interquartile range: 40 to 87), the composite endpoint occurred in 56 of 521 patients (10.8%). Clusters 2 (hazard ratio: 2.37; 95% confidence interval: 1.15 to 4.88) and 3 (hazard ratio: 2.19; 95% confidence interval: 1.00 to 4.82) had a similar outcome, which was worse than cluster 1. CONCLUSIONS Cluster analysis of echocardiographic variables identified 3 different echocardiographic phenotypes of T2DM patients that were associated with distinct clinical profiles and highlighted the prognostic value of LV remodeling and subclinical dysfunction.
Collapse
Affiliation(s)
- Laura Ernande
- Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France; INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Etienne Audureau
- Biostatistics Department, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France; CEpiA EA7376, DHU Ageing-Thorax-Vessel-Blood, Université Paris Est (UPEC), Créteil, France
| | | | - Cyrille Bergerot
- Centre d'Investigation Clinique INSERM 1407 Louis Pradel Hospital, Hospices Civils de Lyon, Bron, France
| | - Corneliu Henegar
- INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Daigo Sawaki
- INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Gabor Czibik
- INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Chiara Volpi
- Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Florence Canoui-Poitrine
- Biostatistics Department, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France; CEpiA EA7376, DHU Ageing-Thorax-Vessel-Blood, Université Paris Est (UPEC), Créteil, France
| | - Hélène Thibault
- Service d'Explorations Fonctionnelles Cardiovasculaires, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France; INSERM UMR-1060, CarMeN Laboratory, Université Claude Bernard Lyon, Lyon, France
| | - Julien Ternacle
- Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France; INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France
| | - Philippe Moulin
- INSERM UMR-1060, CarMeN Laboratory, Université Claude Bernard Lyon, Lyon, France; Fédération d'endocrinologie, Hospices Civils de Lyon, Bron, France
| | | | - Geneviève Derumeaux
- Physiology Department, DHU Ageing-Thorax-Vessel-Blood, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France; INSERM U955, Team08, Université Paris-Est Créteil (UPEC), Créteil, France.
| |
Collapse
|
23
|
Bergerot C, Davidsen ES, Amaz C, Thibault H, Altman M, Bellaton A, Moulin P, Derumeaux G, Ernande L. Diastolic function deterioration in type 2 diabetes mellitus: predictive factors over a 3-year follow-up. Eur Heart J Cardiovasc Imaging 2017; 19:67-73. [DOI: 10.1093/ehjci/jew331] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Accepted: 12/21/2016] [Indexed: 12/11/2022] Open
|
24
|
Schaaf M, Des Horts TB, Croisille P, Roubille F, Prunier F, Garcia Dorado D, Jossan C, Bergerot C, Thibault H, Ovize M, Mewton N. 0488 : Predictive value of early cardiac magnetic resonance left ventricular indices at the acute phase of myocardial infarction on chronic left ventricular remodeling. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30408-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Schaaf M, Andre P, Altman M, Maucort-Boulch D, Placide J, Chevalier P, Bergerot C, Thibault H. Left atrial remodelling assessed by 2D and 3D echocardiography identifies paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging 2016; 18:46-53. [DOI: 10.1093/ehjci/jew028] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/07/2016] [Accepted: 02/02/2016] [Indexed: 01/28/2023] Open
|
26
|
|
27
|
Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Randé JL, Unterseeh T, Le Breton H, Béard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med 2015; 373:1021-31. [PMID: 26321103 DOI: 10.1056/nejmoa1505489] [Citation(s) in RCA: 481] [Impact Index Per Article: 53.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS In a multicenter, double-blind, randomized trial, we assigned 970 patients with an acute anterior ST-segment elevation myocardial infarction (STEMI) who were undergoing percutaneous coronary intervention (PCI) within 12 hours after symptom onset and who had complete occlusion of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenously at a dose of 2.5 mg per kilogram of body weight) or matching placebo before coronary recanalization. The primary outcome was a composite of death from any cause, worsening of heart failure during the initial hospitalization, rehospitalization for heart failure, or adverse left ventricular remodeling at 1 year. Adverse left ventricular remodeling was defined as an increase of 15% or more in the left ventricular end-diastolic volume. RESULTS A total of 395 patients in the cyclosporine group and 396 in the placebo group received the assigned study drug and had data that could be evaluated for the primary outcome at 1 year. The rate of the primary outcome was 59.0% in the cyclosporine group and 58.1% in the control group (odds ratio, 1.04; 95% confidence interval [CI], 0.78 to 1.39; P=0.77). Cyclosporine did not reduce the incidence of the separate clinical components of the primary outcome or other events, including recurrent infarction, unstable angina, and stroke. No significant difference in the safety profile was observed between the two treatment groups. CONCLUSIONS In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.).
Collapse
Affiliation(s)
- Thien-Tri Cung
- From Centre Hospitalier Universitaire (CHU) Arnaud de Villeneuve (T.-T.C.) and Clinique du Millénaire (C.P.), Montpellier, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg (O.M.), CHU de Nimes, Nimes (G.C.), Hôpital Cardiovasculaire Louis Pradel (G. Rioufol, E.B.-C., C.B., I.B., C.J., G.D., N.M., M.O.), Claude Bernard University (G. Rioufol, E.B.-C., C.B., I.B., C.J., G.D., N.M., M.O.), Centre Hospitalier Saint-Joseph et Saint-Luc (J.-F.A.), Clinique de la Sauvegarde (V.M.), Clinique du Tonkin (P.S.), Clinical Investigation Center and Explorations Fonctionnelles Cardiovasculaires (C.B., I.B., C.J., G.D., N.M., M.O.), Lyon, CHU de Tours (D.A.) and Clinique Saint-Gatien (D.B.), Tours, Hôpital Guillaume et René Laennec, Nantes (P.G.), CHU de Rangueil, Toulouse (M.E.), Centre Hospitalier de Pau, Pau (N.D.), Hôpital Haut Lévèque, Bordeaux (P. Coste), Hôpital A. Michallon-CHU de Grenoble, Grenoble (G.V.), Hôpital Henri Duffau, Avignon (M.M.), Centre Hospitalier du Pays d'Aix, Aix-en-Provence (B.J.), Hôpital Gabriel Montpied, Clermont Ferrand (P.M.), Hôpital Charles Nicolle, Rouen (C.T.), Clinique de la Fourcade, Bayonne (J.-N.L.), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris (P.G.S.), Hôpital du Bocage, Dijon (Y.C.), Centre Hospitalier General, Chartres (G. Range), Centre Hospitalier de Compiègne, Compiègne (J.C.), CHU d'Angers, Angers (F.P.), CHU de Nancy-Brabois, Vandœuvre-lès-Nancy (F.M.), CHU de Mulhouse (O.R.) and Clinique du Diaconat (O.I.), Mulhouse, Centre Hospitalier d'Annecy, Annecy (L.B.), Polyclinique des Fleurs, Ollioules (P.B.), Hôpital de La Cavale Blanche, Brest (M.G.), Clinique Esquirol, Agen (P. Colin, F.D.P.), Institut Jacques Cartier, Massy (M.-C.M.), Centre Hospitalier Henri Mondor, Créteil (J.-L.D.-R.), Hôpital Claude Galien, Quincy sous Sénat (T.U.), Hôpital Pontchaillou, Rennes (H.L.B.), Clinique de l'Ormeau, Tarbes (T.B.), Hôpital de la Côte de Nacre, Caen (G.G.), and Hôpital Cardi
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Altman M, Ernande L, Bergerot C, Derumeaux G. Should we search for linear correlations between global strain parameters and ejection fraction? Reply. Eur Heart J Cardiovasc Imaging 2014; 15:1301-2. [DOI: 10.1093/ehjci/jeu187] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Thuny F, Lovric D, Schnell F, Bergerot C, Ernande L, Cottin V, Derumeaux G, Croisille P. Quantification of Myocardial Extracellular Volume Fraction with Cardiac MR Imaging for Early Detection of Left Ventricle Involvement in Systemic Sclerosis. Radiology 2014; 271:373-80. [DOI: 10.1148/radiol.13131280] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
30
|
Courand PY, Dauphin R, Rouvière O, Paget V, Khettab F, Bergerot C, Harbaoui B, Bricca G, Fauvel JP, Lantelme P. [Renal denervation for treating hypertension: experience at the University Hospital in Lyon]. Ann Cardiol Angeiol (Paris) 2014; 63:183-8. [PMID: 24908520 DOI: 10.1016/j.ancard.2014.04.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2014] [Accepted: 04/08/2014] [Indexed: 10/25/2022]
Abstract
AIM We report the first experience of Lyon's university hospital regarding renal denervation to treat patients with resistant essential hypertension. PATIENTS AND METHODS Over a one-year period, 17 patients were treated (12 men, 5 women) with renal denervation. Baseline characteristics were as follows: age 56.5±11.5 years, BMI 33±5kg/m(2) and ambulatory blood pressure 157±16/87±13mmHg with 4.2±1.5 anti-hypertensive treatment. RESULTS We did not observe intra-operative or early complications. After a median follow-up of 3 months and with the same anti-hypertensive treatment, office systolic blood pressure (SBP) and diastolic blood pressure (DBP) decrease respectively of 20±15 (P<0.001) and 10±13mmHg (P=0.014) (n=17). After six months of follow-up, ambulatory blood pressure (ABPM) decrease of 17.5±14.9mmHg (P=0.027) for SBP and of 10.5±9.6mmHg (P=0.029) for DBP (n=6). Among these patients, five of them were controlled (ABPM inferior to 130/80mmHg) and electrical left ventricular hypertrophy indexes decreased: R wave in aVL lead of 4±3mm (P=0.031), Sokolow index of 3±3mm (P=0.205), Cornell voltage criterion of 9±7mm (P=0.027) and Cornell product of 1310±1104 (P=0.027). CONCLUSION Our results are in accordance with data from other centers. On average blood pressure decreases significantly but important inter individual variations are observed. The procedure seems safe.
Collapse
Affiliation(s)
- P-Y Courand
- Service de cardiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France; EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France; Hôpital Nord-Ouest, 69400 Villefranche sur Saône, France.
| | - R Dauphin
- Service de cardiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France; EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France; Hôpital Nord-Ouest, 69400 Villefranche sur Saône, France
| | - O Rouvière
- Service de radiologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69008 Lyon, France; EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France; Hôpital Nord-Ouest, 69400 Villefranche sur Saône, France
| | - V Paget
- Service de cardiologie, hôpital Nord-Ouest, 69008 Villefranche sur Saône, France
| | - F Khettab
- Service de cardiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France
| | - C Bergerot
- Service de cardiologie, hôpital Louis-Pradel, hospices civils de Lyon, 69400 Lyon, France
| | - B Harbaoui
- Service de cardiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France
| | - G Bricca
- EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France
| | - J-P Fauvel
- Service de néphrologie, hôpital Edouard-Herriot, hospices civils de Lyon, 69008 Lyon, France; EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France; Hôpital Nord-Ouest, 69400 Villefranche sur Saône, France
| | - P Lantelme
- Service de cardiologie, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, grande rue de la Croix-Rousse, 69004 Lyon, France; EA 4173, génomique fonctionnelle de l'hypertension artérielle, université Claude-Bernard Lyon1, 69100 Villeurbanne, France; Hôpital Nord-Ouest, 69400 Villefranche sur Saône, France
| |
Collapse
|
31
|
Bergerot C, Mewton N, Lacote-Roiron C, Ernande L, Ovize M, Croisille P, Thibault H, Derumeaux G. Influence of Microvascular Obstruction on Regional Myocardial Deformation in the Acute Phase of Myocardial Infarction: A Speckle-Tracking Echocardiography Study. J Am Soc Echocardiogr 2014; 27:93-100. [DOI: 10.1016/j.echo.2013.09.011] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Indexed: 10/26/2022]
|
32
|
Caiani E, Pellegrini A, Carminati M, Lang R, Auricchio A, Vaida P, Obase K, Sakakura T, Komeda M, Okura H, Yoshida K, Zeppellini R, Noni M, Rigo T, Erente G, Carasi M, Costa A, Ramondo B, Thorell L, Akesson-Lindow T, Shahgaldi K, Germanakis I, Fotaki A, Peppes S, Sifakis S, Parthenakis F, Makrigiannakis A, Richter U, Sveric K, Forkmann M, Wunderlich C, Strasser R, Djikic D, Potpara T, Polovina M, Marcetic Z, Peric V, Ostenfeld E, Werther-Evaldsson A, Engblom H, Ingvarsson A, Roijer A, Meurling C, Holm J, Radegran G, Carlsson M, Tabuchi H, Yamanaka T, Katahira Y, Tanaka M, Kurokawa T, Nakajima H, Ohtsuki S, Saijo Y, Yambe T, D'alto M, Romeo E, Argiento P, D'andrea A, Vanderpool R, Correra A, Sarubbi B, Calabro' R, Russo M, Naeije R, Saha SK, Warsame TA, Caelian AG, Malicse M, Kiotsekoglou A, Omran AS, Sharif D, Sharif-Rasslan A, Shahla C, Khalil A, Rosenschein U, Erturk M, Oner E, Kalkan A, Pusuroglu H, Ozyilmaz S, Akgul O, Aksu H, Akturk F, Celik O, Uslu N, Bandera F, Pellegrino M, Generati G, Donghi V, Alfonzetti E, Guazzi M, Rangel I, Goncalves A, Sousa C, Correia A, Martins E, Silva-Cardoso J, Macedo F, Maciel M, Lee S, Kim W, Yun H, Jung L, Kim E, Ko J, Enescu O, Florescu M, Rimbas R, Cinteza M, Vinereanu D, Kosmala W, Rojek A, Cielecka-Prynda M, Laczmanski L, Mysiak A, Przewlocka-Kosmala M, Liu D, Hu K, Niemann M, Herrmann S, Cikes M, Gaudron P, Knop S, Ertl G, Bijnens B, Weidemann F, Saravi M, Tamadoni A, Jalalian R, Hojati M, Ramezani S, Yildiz A, Inci U, Bilik M, Yuksel M, Oyumlu M, Kayan F, Ozaydogdu N, Aydin M, Akil M, Tekbas E, Shang Q, Zhang Q, Fang F, Wang S, Li R, Lee AP, Yu C, Mornos C, Ionac A, Cozma D, Popescu I, Ionescu G, Dan R, Petrescu L, Sawant A, Srivatsa S, Adhikari P, Mills P, Srivatsa S, Boshchenko A, Vrublevsky A, Karpov R, Trifunovic D, Stankovic S, Vujisic-Tesic B, Petrovic M, Nedeljkovic I, Banovic M, Tesic M, Petrovic M, Dragovic M, Ostojic M, Zencirci E, Esen Zencirci A, Degirmencioglu A, Karakus G, Ekmekci A, Erdem A, Ozden K, Erer H, Akyol A, Eren M, Zamfir D, Tautu O, Onciul S, Marinescu C, Onut R, Comanescu I, Oprescu N, Iancovici S, Dorobantu M, Melao F, Pereira M, Ribeiro V, Oliveira S, Araujo C, Subirana I, Marrugat J, Dias P, Azevedo A, Grillo MT, Piamonti B, Abate E, Porto A, Dell'angela L, Gatti G, Poletti A, Pappalardo A, Sinagra G, Pinto-Teixeira P, Galrinho A, Branco L, Fiarresga A, Sousa L, Cacela D, Portugal G, Rio P, Abreu J, Ferreira R, Fadel B, Abdullah N, Al-Admawi M, Pergola V, Bech-Hanssen O, Di Salvo G, Tigen MK, Pala S, Karaahmet T, Dundar C, Bulut M, Izgi A, Esen AM, Kirma C, Boerlage-Van Dijk K, Yamawaki M, Wiegerinck E, Meregalli P, Bindraban N, Vis M, Koch K, Piek J, Bouma B, Baan J, Mizia M, Sikora-Puz A, Gieszczyk-Strozik K, Lasota B, Chmiel A, Chudek J, Jasinski M, Deja M, Mizia-Stec K, Silva Fazendas Adame PR, Caldeira D, Stuart B, Almeida S, Cruz I, Ferreira A, Lopes L, Joao I, Cotrim C, Pereira H, Unger P, Dedobbeleer C, Stoupel E, Preumont N, Argacha J, Berkenboom G, Van Camp G, Malev E, Reeva S, Vasina L, Pshepiy A, Korshunova A, Timofeev E, Zemtsovsky E, Jorgensen PG, Jensen J, Fritz-Hansen T, Biering-Sorensen T, Jons C, Olsen N, Henri C, Magne J, Dulgheru R, Laaraibi S, Voilliot D, Kou S, Pierard L, Lancellotti P, Tayyareci Y, Dworakowski R, Kogoj P, Reiken J, Kenny C, Maccarthy P, Wendler O, Monaghan M, Song J, Ha T, Jung Y, Seo M, Choi S, Kim Y, Sun B, Kim D, Kang D, Song J, Le Tourneau T, Topilsky Y, Inamo J, Mahoney D, Suri R, Schaff H, Enriquez-Sarano M, Bonaque Gonzalez J, Sanchez Espino A, Merchan Ortega G, Bolivar Herrera N, Ikuta I, Macancela Quinonez J, Munoz Troyano S, Ferrer Lopez R, Gomez Recio M, Dreyfus J, Cimadevilla C, Brochet E, Himbert D, Iung B, Vahanian A, Messika-Zeitoun D, Izumo M, Takeuchi M, Seo Y, Yamashita E, Suzuki K, Ishizu T, Sato K, Aonuma K, Otsuji Y, Akashi Y, Muraru D, Addetia K, Veronesi F, Corsi C, Mor-Avi V, Yamat M, Weinert L, Lang R, Badano L, Minamisawa M, Koyama J, Kozuka A, Motoki H, Izawa A, Tomita T, Miyashita Y, Ikeda U, Florescu C, Niemann M, Liu D, Hu K, Herrmann S, Gaudron P, Scholz F, Stoerk S, Ertl G, Weidemann F, Marchel M, Serafin A, Kochanowski J, Piatkowski R, Madej-Pilarczyk A, Filipiak K, Hausmanowa-Petrusewicz I, Opolski G, Meimoun P, M'barek D, Clerc J, Neikova A, Elmkies F, Tzvetkov B, Luycx-Bore A, Cardoso C, Zemir H, Mansencal N, Arslan M, El Mahmoud R, Pilliere R, Dubourg O, Ikonomidis I, Lambadiari V, Pavlidis G, Koukoulis C, Kousathana F, Varoudi M, Tritakis V, Triantafyllidi H, Dimitriadis G, Lekakis I, Kovacs A, Kosztin A, Solymossy K, Celeng C, Apor A, Faludi M, Berta K, Szeplaki G, Foldes G, Merkely B, Kimura K, Daimon M, Nakajima T, Motoyoshi Y, Komori T, Nakao T, Kawata T, Uno K, Takenaka K, Komuro I, Gabric ID, Vazdar L, Pintaric H, Planinc D, Vinter O, Trbusic M, Bulj N, Nobre Menezes M, Silva Marques J, Magalhaes R, Carvalho V, Costa P, Brito D, Almeida A, Nunes-Diogo A, Davidsen ES, Bergerot C, Ernande L, Barthelet M, Thivolet S, Decker-Bellaton A, Altman M, Thibault H, Moulin P, Derumeaux G, Huttin O, Voilliot D, Frikha Z, Aliot E, Venner C, Juilliere Y, Selton-Suty C, Yamada T, Ooshima M, Hayashi H, Okabe S, Johno H, Murata H, Charalampopoulos A, Tzoulaki I, Howard L, Davies R, Gin-Sing W, Grapsa J, Wilkins M, Gibbs J, Castillo J, Bandeira A, Albuquerque E, Silveira C, Pyankov V, Chuyasova Y, Lichodziejewska B, Goliszek S, Kurnicka K, Dzikowska Diduch O, Kostrubiec M, Krupa M, Grudzka K, Ciurzynski M, Palczewski P, Pruszczyk P, Arana X, Oria G, Onaindia J, Rodriguez I, Velasco S, Cacicedo A, Palomar S, Subinas A, Zumalde J, Laraudogoitia E, Saeed S, Kokorina M, Fromm A, Oeygarden H, Waje-Andreassen U, Gerdts E, Gomez E, Vallejo N, Pedro-Botet L, Mateu L, Nunyez R, Llobera L, Bayes A, Sabria M, Antonini-Canterin F, Mateescu A, La Carrubba S, Vriz O, Di Bello V, Carerj S, Zito C, Ginghina C, Popescu B, Nicolosi G, Mateescu A, La Carrubba S, Vriz O, Di Bello V, Carerj S, Zito C, Ginghina C, Popescu B, Nicolosi G, Antonini-Canterin F, Pudil R, Praus R, Vasatova M, Vojacek J, Palicka V, Hulek P, Pradel S, Mohty D, Damy T, Echahidi N, Lavergne D, Virot P, Aboyans V, Jaccard A, Mateescu A, La Carrubba S, Vriz O, Di Bello V, Carerj S, Zito C, Ginghina C, Popescu B, Nicolosi G, Antonini-Canterin F, Doulaptsis C, Symons R, Matos A, Florian A, Masci P, Dymarkowski S, Janssens S, Bogaert J, Lestuzzi C, Moreo A, Celik S, Lafaras C, Dequanter D, Tomkowski W, De Biasio M, Cervesato E, Massa L, Imazio M, Watanabe N, Kijima Y, Akagi T, Toh N, Oe H, Nakagawa K, Tanabe Y, Ikeda M, Okada K, Ito H, Milanesi O, Biffanti R, Varotto E, Cerutti A, Reffo E, Castaldi B, Maschietto N, Vida V, Padalino M, Stellin G, Bejiqi R, Retkoceri R, Bejiqi H, Retkoceri A, Surdulli S, Massoure P, Cautela J, Roche N, Chenilleau M, Gil J, Fourcade L, Akhundova A, Cincin A, Sunbul M, Sari I, Tigen M, Basaran Y, Suermeci G, Butz T, Schilling I, Sasko B, Liebeton J, Van Bracht M, Tzikas S, Prull M, Wennemann R, Trappe H, Attenhofer Jost CH, Pfyffer M, Scharf C, Seifert B, Faeh-Gunz A, Naegeli B, Candinas R, Medeiros-Domingo A, Wierzbowska-Drabik K, Roszczyk N, Sobczak M, Plewka M, Krecki R, Kasprzak J, Ikonomidis I, Varoudi M, Papadavid E, Theodoropoulos K, Papadakis I, Pavlidis G, Triantafyllidi H, Anastasiou - Nana M, Rigopoulos D, Lekakis J, Tereshina O, Surkova E, Vachev A, Merchan Ortega G, Bonaque Gonzalez J, Sanchez Espino A, Bolivar Herrera N, Bravo Bustos D, Ikuta I, Aguado Martin M, Navarro Garcia F, Ruiz Lopez F, Gomez Recio M, Merchan Ortega G, Bonaque Gonzalez J, Bravo Bustos D, Sanchez Espino A, Bolivar Herrera N, Bonaque Gonzalez J, Navarro Garcia F, Aguado Martin M, Ruiz Lopez M, Gomez Recio M, Eguchi H, Maruo T, Endo K, Nakamura K, Yokota K, Fuku Y, Yamamoto H, Komiya T, Kadota K, Mitsudo K, Nagy AI, Manouras A, Gunyeli E, Shahgaldi K, Winter R, Hoffmann R, Barletta G, Von Bardeleben S, Kasprzak J, Greis C, Vanoverschelde J, Becher H, Hu K, Liu D, Niemann M, Herrmann S, Cikes M, Gaudron P, Knop S, Ertl G, Bijnens B, Weidemann F, Di Salvo G, Al Bulbul Z, Issa Z, Khan A, Faiz A, Rahmatullah S, Fadel B, Siblini G, Al Fayyadh M, Menting ME, Van Den Bosch A, Mcghie J, Cuypers J, Witsenburg M, Van Dalen B, Geleijnse M, Roos-Hesselink J, Olsen F, Jorgensen P, Mogelvang R, Jensen J, Fritz-Hansen T, Bech J, Biering-Sorensen T, Agoston G, Pap R, Saghy L, Forster T, Varga A, Scandura S, Capodanno D, Dipasqua F, Mangiafico S, Caggegi AM, Grasso C, Pistritto AM, Imme' S, Ministeri M, Tamburino C, Cameli M, Lisi M, D'ascenzi F, Cameli P, Losito M, Sparla S, Lunghetti S, Favilli R, Fineschi M, Mondillo S, Ojaghihaghighi Z, Javani B, Haghjoo M, Moladoust H, Shahrzad S, Ghadrdoust B, Altman M, Aussoleil A, Bergerot C, Bonnefoy-Cudraz E, Derumeaux GA, Thibault H, Shkolnik E, Vasyuk Y, Nesvetov V, Shkolnik L, Varlan G, Gronkova N, Kinova E, Borizanova A, Goudev A, Saracoglu E, Ural D, Sahin T, Al N, Cakmak H, Akbulut T, Akay K, Ural E, Mushtaq S, Andreini D, Pontone G, Bertella E, Conte E, Baggiano A, Annoni A, Formenti A, Fiorentini C, Pepi M, Cosgrove C, Carr L, Chao C, Dahiya A, Prasad S, Younger J, Biering-Sorensen T, Christensen L, Krieger D, Mogelvang R, Jensen J, Hojberg S, Host N, Karlsen F, Christensen H, Medressova A, Abikeyeva L, Dzhetybayeva S, Andossova S, Kuatbayev Y, Bekbossynova M, Bekbossynov S, Pya Y, Farsalinos K, Tsiapras D, Kyrzopoulos S, Spyrou A, Stefopoulos C, Romagna G, Tsimopoulou K, Tsakalou M, Voudris V, Cacicedo A, Velasco Del Castillo S, Anton Ladislao A, Aguirre Larracoechea U, Onaindia Gandarias J, Romero Pereiro A, Arana Achaga X, Zugazabeitia Irazabal G, Laraudogoitia Zaldumbide E, Lekuona Goya I, Varela A, Kotsovilis S, Salagianni M, Andreakos V, Davos C, Merchan Ortega G, Bonaque Gonzalez J, Sanchez Espino A, Bolivar Herrera N, Macancela Quinones J, Ikuta I, Ferrer Lopez R, Munoz Troyano S, Bravo Bustos D, Gomez Recio M. Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet206] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
33
|
Abdovic E, Abdovic S, Hristova K, Hristova K, Katova T, Katova T, Gocheva N, Gocheva N, Pavlova M, Pavlova M, Gurzun MM, Ionescu A, Canpolat U, Yorgun H, Sunman H, Sahiner L, Kaya E, Ozer N, Tokgozoglu L, Kabakci G, Aytemir K, Oto A, Gonella A, D'ascenzo F, Casasso F, Conte E, Margaria F, Grosso Marra W, Frea S, Morello M, Bobbio M, Gaita F, Seo H, Lee S, Lee J, Yoon Y, Park E, Kim H, Park S, Lee H, Kim Y, Sohn D, Nemes A, Domsik P, Kalapos A, Orosz A, Lengyel C, Forster T, Enache R, Muraru D, Popescu B, Calin A, Nastase O, Botezatu D, Purcarea F, Rosca M, Beladan C, Ginghina C, Canpolat U, Aytemir K, Ozer N, Yorgun H, Sahiner L, Kaya E, Oto A, Muraru D, Piasentini E, Mihaila S, Padayattil Jose' S, Peluso D, Ucci L, Naso P, Puma L, Iliceto S, Badano L, Cikes M, Jakus N, Sutherland G, Haemers P, D'hooge J, Claus P, Yurdakul S, Oner F, Direskeneli H, Sahin T, Cengiz B, Ercan G, Bozkurt A, Aytekin S, Osa Saez AM, Rodriguez-Serrano M, Lopez-Vilella R, Buendia-Fuentes F, Domingo-Valero D, Quesada-Carmona A, Miro-Palau V, Arnau-Vives M, Palencia-Perez M, Rueda-Soriano J, Lipczynska M, Piotr Szymanski P, Anna Klisiewicz A, Lukasz Mazurkiewicz L, Piotr Hoffman P, Kim K, Cho S, Ahn Y, Jeong M, Cho J, Park J, Chinali M, Franceschini A, Matteucci M, Doyon A, Esposito C, Del Pasqua A, Rinelli G, Schaefer F, Kowalik E, Klisiewicz A, Rybicka J, Szymanski P, Biernacka E, Hoffman P, Lee S, Kim W, Yun H, Jung L, Kim E, Ko J, Ruddox V, Norum I, Edvardsen T, Baekkevar M, Otterstad J, Erdei T, Edwards J, Braim D, Yousef Z, Fraser A, Melcher A, Reiner B, Hansen A, Strandberg L, Caidahl K, Wellnhofer E, Kriatselis C, Gerd-Li H, Furundzija V, Thnabalasingam U, Fleck E, Graefe M, Park Y, Moon J, Ahn T, Baydar O, Kadriye Kilickesmez K, Ugur Coskun U, Polat Canbolat P, Veysel Oktay V, Umit Yasar Sinan U, Okay Abaci O, Cuneyt Kocas C, Sinan Uner S, Serdar Kucukoglu S, Ferferieva V, Claus P, Rademakers F, D'hooge J, Le TT, Wong P, Tee N, Huang F, Tan R, Altman M, Logeart D, Bergerot C, Gellen B, Pare C, Gerard S, Sirol M, Vicaut E, Mercadier J, Derumeaux GA, Park TH, Park JI, Shin SW, Yun SH, Lee JE, Makavos G, Kouris N, Keramida K, Dagre A, Ntarladimas I, Kostopoulos V, Damaskos D, Olympios C, Leong D, Piers S, Hoogslag G, Hoke U, Thijssen J, Ajmone Marsan N, Schalij M, Bax J, Zeppenfeld K, Delgado V, Rio P, Branco L, Galrinho A, Cacela D, Abreu J, Timoteo A, Teixeira P, Pereira-Da-Silva T, Selas M, Cruz Ferreira R, Popa BA, Zamfir L, Novelli E, Lanzillo G, Karazanishvili L, Musica G, Stelian E, Benea D, Diena M, Cerin G, Fusini L, Mirea O, Tamborini G, Muratori M, Gripari P, Ghulam Ali S, Cefalu' C, Maffessanti F, Andreini D, Pepi M, Mamdoo F, Goncalves A, Peters F, Matioda H, Govender S, Dos Santos C, Essop M, Kuznetsov VA, Yaroslavskaya EI, Pushkarev GS, Krinochkin DV, Kolunin GV, Bennadji A, Hascoet S, Dulac Y, Hadeed K, Peyre M, Ricco L, Clement L, Acar P, Ding W, Zhao Y, Lindqvist P, Nilson J, Winter R, Holmgren A, Ruck A, Henein M, Illatopa V, Cordova F, Espinoza D, Ortega J, Cavalcante J, Patel M, Katz W, Schindler J, Crock F, Khanna M, Khandhar S, Tsuruta H, Kohsaka S, Murata M, Yasuda R, Tokuda H, Kawamura A, Maekawa Y, Hayashida K, Fukuda K, Le Tourneau T, Kyndt F, Lecointe S, Duval D, Rimbert A, Merot J, Trochu J, Probst V, Le Marec H, Schott J, Veronesi F, Addetia K, Corsi C, Lamberti C, Lang R, Mor-Avi V, Gjerdalen GF, Hisdal J, Solberg E, Andersen T, Radunovic Z, Steine K, Maffessanti F, Gripari P, Tamborini G, Muratori M, Fusini L, Ferrari C, Caiani E, Alamanni F, Bartorelli A, Pepi M, D'ascenzi F, Cameli M, Iadanza A, Lisi M, Reccia R, Curci V, Sinicropi G, Henein M, Pierli C, Mondillo S, Rekhraj S, Hoole S, Mcnab D, Densem C, Boyd J, Parker K, Shapiro L, Rana B, Kotrc M, Vandendriessche T, Bartunek J, Claeys M, Vanderheyden M, Paelinck B, De Bock D, De Maeyer C, Vrints C, Penicka M, Silveira C, Albuquerque E, Lamprea D, Larangeiras V, Moreira C, Victor Filho M, Alencar B, Silveira A, Castillo J, Zambon E, Iorio A, Carriere C, Pantano A, Barbati G, Bobbo M, Abate E, Pinamonti B, Di Lenarda A, Sinagra G, Salemi VMC, Tavares L, Ferreira Filho J, Oliveira A, Pessoa F, Ramires F, Fernandes F, Mady C, Cavarretta E, Lotrionte M, Abbate A, Mezzaroma E, De Marco E, Peruzzi M, Loperfido F, Biondi-Zoccai G, Frati G, Palazzoni G, Park TH, Lee JE, Lee DH, Park JS, Park K, Kim MH, Kim YD, Van 'T Sant J, Gathier W, Leenders G, Meine M, Doevendans P, Cramer M, Poyhonen P, Kivisto S, Holmstrom M, Hanninen H, Schnell F, Betancur J, Daudin M, Simon A, Carre F, Tavard F, Hernandez A, Garreau M, Donal E, Calore C, Muraru D, Badano L, Melacini P, Mihaila S, Denas G, Naso P, Casablanca S, Santi F, Iliceto S, Aggeli C, Venieri E, Felekos I, Anastasakis A, Ritsatos K, Kakiouzi V, Kastellanos S, Cutajar I, Stefanadis C, Palecek T, Honzikova J, Poupetova H, Vlaskova H, Kuchynka P, Linhart A, Elmasry O, Mohamed M, Elguindy W, Bishara P, Garcia-Gonzalez P, Cozar-Santiago P, Bochard-Villanueva B, Fabregat-Andres O, Cubillos-Arango A, Valle-Munoz A, Ferrer-Rebolleda J, Paya-Serrano R, Estornell-Erill J, Ridocci-Soriano F, Jensen M, Havndrup O, Christiansen M, Andersen P, Axelsson A, Kober L, Bundgaard H, Karapinar H, Kaya A, Uysal E, Guven A, Kucukdurmaz Z, Oflaz M, Deveci K, Sancakdar E, Gul I, Yilmaz A, Tigen MK, Karaahmet T, Dundar C, Yalcinsoy M, Tasar O, Bulut M, Takir M, Akkaya E, Jedrzejewska I, Braksator W, Krol W, Swiatowiec A, Dluzniewski M, Lipari P, Bonapace S, Zenari L, Valbusa F, Rossi A, Lanzoni L, Molon G, Canali G, Campopiano E, Barbieri E, Rueda Calle E, Alfaro Rubio F, Gomez Gonzalez J, Gonzalez Santos P, Cameli M, Lisi M, Focardi M, D'ascenzi F, Solari M, Galderisi M, Mondillo S, Pratali L, Bruno RM, Corciu A, Comassi M, Passera M, Gastaldelli A, Mrakic-Sposta S, Vezzoli A, Picano E, Perry R, Penhall A, De Pasquale C, Selvanayagam J, Joseph M, Simova II, Katova TM, Kostova V, Hristova K, Lalov I, D'ascenzi F, Pelliccia A, Natali B, Cameli M, Alvino F, Zorzi A, Corrado D, Bonifazi M, Mondillo S, Rees E, Rakebrandt F, Rees D, Halcox J, Fraser A, O'driscoll J, Lau N, Perez-Lopez M, Sharma R, Lichodziejewska B, Goliszek S, Kurnicka K, Kostrubiec M, Dzikowska Diduch O, Krupa M, Grudzka K, Ciurzynski M, Palczewski P, Pruszczyk P, Gheorghe L, Castillo Ortiz J, Del Pozo Contreras R, Calle Perez G, Sancho Jaldon M, Cabeza Lainez P, Vazquez Garcia R, Fernandez Garcia P, Chueca Gonzalez E, Arana Granados R, Zhao X, Xu X, Bai Y, Qin Y, Leren I, Hasselberg N, Saberniak J, Leren T, Edvardsen T, Haugaa K, Daraban AM, Sutherland G, Claus P, Werner B, Gewillig M, Voigt J, Santoro A, Ierano P, De Stefano F, Esposito R, De Palma D, Ippolito R, Tufano A, Galderisi M, Costa R, Fischer C, Rodrigues A, Monaco C, Lira Filho E, Vieira M, Cordovil A, Oliveira E, Mohry S, Gaudron P, Niemann M, Herrmann S, Strotmann J, Beer M, Hu K, Bijnens B, Ertl G, Weidemann F, Baktir A, Sarli B, Cicek M, Karakas M, Saglam H, Arinc H, Akil M, Kaya H, Ertas F, Bilik M, Yildiz A, Oylumlu M, Acet H, Aydin M, Yuksel M, Alan S, O'driscoll J, Gravina A, Di Fino S, Thompson M, Karthigelasingham A, Ray K, Sharma R, De Chiara B, Russo C, Alloni M, Belli O, Spano' F, Botta L, Palmieri B, Martinelli L, Giannattasio C, Moreo A, Mateescu A, La Carrubba S, Vriz O, Di Bello V, Carerj S, Zito C, Ginghina C, Popescu B, Nicolosi G, Antonini-Canterin F, Malev E, Omelchenko M, Vasina L, Luneva E, Zemtsovsky E, Cikes M, Velagic V, Gasparovic H, Kopjar T, Colak Z, Hlupic L, Biocina B, Milicic D, Tomaszewski A, Kutarski A, Poterala M, Tomaszewski M, Brzozowski W, Kijima Y, Akagi T, Nakagawa K, Ikeda M, Watanabe N, Ueoka A, Takaya Y, Oe H, Toh N, Ito H, Bochard Villanueva B, Paya-Serrano R, Fabregat-Andres O, Garcia-Gonzalez P, Perez-Bosca J, Cubillos-Arango A, Chacon-Hernandez N, Higueras-Ortega L, De La Espriella-Juan R, Ridocci-Soriano F, Noack T, Mukherjee C, Ionasec R, Voigt I, Kiefer P, Hoebartner M, Misfeld M, Mohr FW, Seeburger J, Daraban AM, Baltussen L, Amzulescu M, Bogaert J, Jassens S, Voigt J, Duchateau N, Giraldeau G, Gabrielli L, Penela D, Evertz R, Mont L, Brugada J, Berruezo A, Bijnens B, Sitges M, Yoshikawa H, Suzuki M, Hashimoto G, Kusunose Y, Otsuka T, Nakamura M, Sugi K, Ruiz Ortiz M, Mesa D, Romo E, Delgado M, Seoane T, Martin M, Carrasco F, Lopez Granados A, Arizon J, Suarez De Lezo J, Magalhaes A, Cortez-Dias N, Silva D, Menezes M, Saraiva M, Santos L, Costa A, Costa L, Nunes Diogo A, Fiuza M, Ren B, De Groot-De Laat L, Mcghie J, Vletter W, Geleijnse M, Toda H, Oe H, Osawa K, Miyoshi T, Ugawa S, Toh N, Nakamura K, Kohno K, Morita H, Ito H, El Ghannudi S, Germain P, Samet H, Jeung M, Roy C, Gangi A, Orii M, Hirata K, Yamano T, Tanimoto T, Ino Y, Yamaguchi T, Kubo T, Imanishi T, Akasaka T, Sunbul M, Kivrak T, Oguz M, Ozguven S, Gungor S, Dede F, Turoglu H, Yildizeli B, Mutlu B, Mihaila S, Muraru D, Piasentini E, Peluso D, Cucchini U, Casablanca S, Naso P, Iliceto S, Vinereanu D, Badano L, Rodriguez Munoz D, Moya Mur J, Becker Filho D, Gonzalez A, Casas Rojo E, Garcia Martin A, Recio Vazquez M, Rincon L, Fernandez Golfin C, Zamorano Gomez J, Ledakowicz-Polak A, Polak L, Zielinska M, Kamiyama T, Nakade T, Nakamura Y, Ando T, Kirimura M, Inoue Y, Sasaki O, Nishioka T, Farouk H, Sakr B, Elchilali K, Said K, Sorour K, Salah H, Mahmoud G, Casanova Rodriguez C, Cano Carrizal R, Iglesias Del Valle D, Martin Penato Molina A, Garcia Garcia A, Prieto Moriche E, Alvarez Rubio J, De Juan Bagua J, Tejero Romero C, Plaza Perez I, Korlou P, Stefanidis A, Mpikakis N, Ikonomidis I, Anastasiadis S, Komninos K, Nikoloudi P, Margos P, Pentzeridis P. Poster session Thursday 12 December - AM: 12/12/2013, 08:30-12:30 * Location: Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Altman M, Bergerot C, Aussoleil A, Davidsen ES, Sibellas F, Ovize M, Bonnefoy-Cudraz E, Thibault H, Derumeaux G. Assessment of left ventricular systolic function by deformation imaging derived from speckle tracking: a comparison between 2D and 3D echo modalities. Eur Heart J Cardiovasc Imaging 2013; 15:316-23. [PMID: 24047866 DOI: 10.1093/ehjci/jet103] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
AIMS Deformation imaging is undergoing continuous development with the emergence of new technologies allowing the evaluation of the different components of strain simultaneously in three dimensions. Assessment of all global strain parameters in 2D and 3D modes and comparison with LVEF have been the focus of our study. METHODS AND RESULTS Out of 166 patients, 147 were evaluated with the use of both 2D and 3D speckle-tracking echocardiography (STE). Global strain parameters including longitudinal (GLS), circumferential (GCS), radial (GRS) and area strain (AS), as well as left ventricular volumes and ejection fraction were examined. Analysis of strain with 3D STE was faster than with 2D STE (7 ± 2 vs. 24 ± 4 min, P < 0.05). GLS values were similar between 2D and 3D modes (-14 ± 4 vs. -13 ± 3, NS), while slight differences were observed for GCS (-24 ± 7 vs. -27 ± 7, P < 0.05) and GRS (27 ± 9 vs. 24 ± 9, P < 0.05). All 2D and 3D strain parameters showed good accuracy in the identification of 2D-LVEF <55% with AS demonstrating superiority over GCS and GRS but not GLS. CONCLUSION Three-dimensional STE allows accurate and faster analysis of deformation when compared with 2D STE and might represent a viable alternative in the evaluation of global LV function.
Collapse
Affiliation(s)
- Mikhail Altman
- Laboratoire d'Echocardiographie Hopital Louis Pradel, 28 Avenue Doyen Lepine BP Lyon, 69677 Bron Cedex, France
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Mewton N, Thibault H, Roubille F, Lairez O, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Cung TT, Finet G, Angoulvant D, Revel D, Bonnefoy-Cudraz E, Elbaz M, Piot C, Sahraoui I, Croisille P, Ovize M. Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 2013; 108:383. [DOI: 10.1007/s00395-013-0383-8] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2013] [Revised: 08/23/2013] [Accepted: 08/26/2013] [Indexed: 02/06/2023]
|
36
|
Altman M, Bergerot C, Aussoleil A, Barthelet M, Carmona C, Thivolet S, Ernande L, Bonnefoy E, Thibault H, Derumeaux GA. Prediction of left ventricular remodelling after acute myocardial infarction by 3D strain echocardiography. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht311.5859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
37
|
Lovric D, Thuny F, Carmona C, Schnell F, Ernande L, Thibault H, Bergerot C, Ninet J, Croisille P, Derumeaux GA. Myocardial extracellular volume fraction by cardiac magnetic resonance for early detection of left ventricular involvement in systemic sclerosis. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Ernande L, Cottin V, Leroux PY, Girerd N, Huez S, Mulliez A, Bergerot C, Ovize M, Mornex JF, Cordier JF, Naeije R, Derumeaux G. Right isovolumic contraction velocity predicts survival in pulmonary hypertension. J Am Soc Echocardiogr 2012; 26:297-306. [PMID: 23265440 DOI: 10.1016/j.echo.2012.11.011] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2012] [Indexed: 11/16/2022]
Abstract
BACKGROUND Right ventricular function is a strong determinant of prognosis in severe pulmonary hypertension. METHODS The aim of this study was to evaluate the prognostic value of estimates of right ventricular function obtained by echocardiography and Doppler tissue imaging and of functional class and 6-min walk distance (6MWD) in 142 patients with either pulmonary arterial hypertension (n = 104) or chronic thromboembolic pulmonary hypertension (n = 38). Echocardiography was prospectively performed, and demographics, medications, associated medical conditions, New York Heart Association class, and 6MWD at inclusion in addition to vital status, transplantation, and hospital admission related to pulmonary hypertension at follow-up were then collected by review of the medical records. RESULTS Variables associated with overall survival by univariate analysis were 6MWD (P = .009), functional class (P = .024), tricuspid annular plane systolic excursion (P = .03) and isovolumic peak velocity at the tricuspid annulus (IVCv) (P = .003). On multivariate analysis, IVCv (P = .015) and 6MWD (P = .016) were the only independent predictors of survival. Kaplan-Meier estimates of survival at 1 year were 95% in patients with IVCv > 9 cm/sec and 80% in those with IVCv ≤ 9 cm/sec (P = .002). Intraobserver and interobserver variability of IVCv measurement were 5% and 9%, respectively. CONCLUSIONS Measurement of right ventricular function by Doppler tissue imaging, an easy, noninvasive, and reproducible method, is an independent predictor of clinical outcomes in patients with severe pulmonary hypertension.
Collapse
Affiliation(s)
- Laura Ernande
- Explorations Fonctionnelles Cardiovasculaires, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Altman M, Bergerot C, Thibault H, Aussoleil A, Skuldadt Davidsen E, Barthelet M, Derumeaux GA, Grapsa J, Zimbarra Cabrita I, Afilalo J, Paschou S, Dawson D, Durighel G, O'regan D, Howard L, Gibbs J, Nihoyannopoulos P, Morenate Navio M, Mesa Rubio M, Ortega MD, Ruiz Ortiz M, Castillo Bernal F, Del Pino CL, Toledano F, Alvarez-Ossorio MP, Ojeda Pineda S, Lezo Cruz-Conde JSD, Jasaityte R, Claus P, Teske A, Herbots L, Verheyden B, Rademakers F, D'hooge J, Tocchetti CG, Coppola C, Rea D, Quintavalle C, Guarino L, Castaldo N, De Lorenzo C, Condorelli G, Arra C, Maurea N, Voilliot D, Huttin O, Camara Y, Djaballah W, Carillo S, Zinzius P, Sellal J, Angioi M, Juilliere Y, Selton-Suty C, Dobrowolski P, Klisiewicz A, Florczak E, Prejbisz A, Szwench E, Rybicka J, Januszewicz A, Hoffman P, Jurado Roman A, De Dios Perez S, De Nicolas JMM, Diaz Anton B, Rubio Alonso B, Martin Asenjo R, Mayordomo Gomez S, Villagraz Tecedor L, Blazquez L, De Meneses RT, Bernard A, Hernandez AI, Reynaud A, Lerclercq C, Daubert J, Donal E, Arjan Singh R, Sivarani S, Lim S, Azman W, Almeida M, Cardim N, Fonseca V, Carmelo V, Santos S, Santos T, Toste J, Kosmala W, Orda A, Karolko B, Mysiak A, Przewlocka-Kosmala M, Farsalinos K, Tsiapras D, Kyrzopoulos S, Avramidou E, Vassilopoulou D, Voudris V, Hayrapetyan H, Adamyan K, Jurado Roman A, De Dios Perez S, Rubio Alonso B, De Nicolas JMM, Diaz Anton B, Martin Asenjo R, Montero Cabezas J, Granda Nistal C, Garcia Aranda B, Sanchez Sanchez V, Sestito A, Lamendola P, Di Franco A, Lauria C, Lanza G, Kukucka M, Unbehaun A, Buz S, Mladenow A, Kuppe H, Pasic M, Habazettl H, Gemma D, Montoro Lopez N, De Celix MGR, Lopez Fernandez T, De Torres Alba F, Del Valle DI, Ramirez U, Mesa J, Moreno Yanguela M, Lopez Sendon J, Eveborn GW, Schirmer H, Lunde P, Heggelund G, Rasmussen K, Wang Z, Lasota B, Mizia-Stec K, Mizia M, Chmiel A, Adamczyk T, Chudek J, Gasior Z, Venkatesh A, Johnson J, Sahlen A, Brodin L, Winter R, Shahgaldi K, Manouras A, Valbuena S, Iniesta A, Lopez T, De Torres F, Salinas P, Garcia S, Ramirez U, Mesa J, Moreno M, Lopez-Sendon J, Lebid I, Kobets T, Kuzmenko T, Katsanos S, Yiu K, Clavel M, Nina Ajmone N, Van Der Kley F, Rodes Cabau J, Schalij M, Bax J, Pibarot P, Delgado V, Fusini L, Tamborini G, Muratori M, Gripari P, Marsan N, Cefalu' C, Ewe S, Maffessanti F, Delgado V, Pepi M, Hasselberg N, Haugaa K, Petri H, Berge K, Leren T, Bundgaard H, Edvardsen T, Ancona R, Comenale Pinto S, Caso P, Coppola M, Rapisarda O, Cavallaro C, Vecchione F, D'onofrio A, Calabro' R, Rimbas R, Mihaila S, Enescu O, Patrascu N, Dragoi R, Rimbas M, Pop C, Vinereanu D, Gustafsson S, Morner S, Gronlund C, Suhr O, Lindqvist P, Di Bella G, Zito C, Minutoli F, Madaffari A, Cusma Piccione M, Mazzeo A, Massimo R, Pasquale M, Vita G, Carerj S, Rangel I, Goncalves A, Sousa C, Correia A, Martins E, Silva-Cardoso J, Macedo F, Maciel M, Pfeiffer B, Rigopoulos A, Seggewiss H, Alvarez Fuente M, Sainz Costa T, Medrano C, Navarro M, Blazquez Gamero D, Ramos J, Mellado M, De Jose M, Munoz M, Maroto E, Gargani L, Gosciniak P, Pratali L, Agoston G, Bruni C, Guiducci S, Matucci Cerinic M, Varga A, Sicari R, Picano E, Yiu K, Zhao C, Mei M, Yeung C, Siu C, Tse H, Florescu M, Enescu O, Magda L, Mincu R, Vinereanu D, Daha I, Stanescu CM, Chirila L, Baicus C, Vlase A, Dan G, Montoro Lopez M, Florez Gomez R, Alonso Ladreda A, Itziar Soto C, Rios Blanco J, Gemma D, De Torres Alba F, Moreno Yanguela M, Lopez Sendon J, Guzman Martinez G, Lichodziejewska B, Kurnicka K, Goliszek S, Kostrubiec M, Dzikowska-Diduch O, Ciurzynski M, Labyk A, Krupa M, Palczewski P, Pruszczyk P, De Sousa CC, Rangel I, Correia A, Martins E, Vigario A, Pinho T, Silva Cardoso J, Goncalves A, Macedo F, Maciel M, Park SJ, Song JE, Lee YJ, Ha MR, Chang SA, Choi JO, Lee SC, Park S, Oh J, Van De Bruaene A, De Meester P, Buys R, Vanhees L, Delcroix M, Voigt J, Budts W, Blundo A, Buccheri S, Monte IP, Leggio S, Tamburino C, Sotaquira M, Fusini L, Maffessanti F, Pepi M, Lang R, Caiani E, Floria M, De Roy L, Xhaet O, Blommaert D, Jamart J, Gerard M, Deceuninck O, Marchandise B, Seldrum S, Schroeder E, Unsworth B, Sohaib S, Kulwant-Kaur K, Malcolme-Lawes L, Kanagaratnam P, Malik I, Ren B, Mulder H, Haak A, Van Stralen M, Szili-Torok T, Pluim J, Geleijnse M, Bosch J, Baglini R, Amaducci A, D'ancona G, Van Den Oord S, Akkus Z, Bosch J, Ten Kate G, Renaud G, Sijbrands E, De Jong N, Van Der Lugt A, Van Der Steen A, Schinkel A, Bjallmark A, Larsson M, Grishenkov D, Brodin LA, Brismar T, Paradossi G, Sveen KA, Nerdrum T, Hanssen K, Dahl-Jorgensen K, Steine K, Cimino S, Pedrizzetti G, Tonti G, Canali E, Petronilli V, Cicogna F, Arcari L, De Luca L, Iacoboni C, Agati L, Abdel Moneim SS, Eifert Rain S, Bernier M, Bhat G, Hagen M, Bott-Kitslaar D, Castello R, Wilansky S, Pellikka P, Mulvagh S, Delithanasis I, Celutkiene J, Kenny C, Monaghan M, Park W, Hong G, Son J, Lee S, Kim U, Park J, Shin D, Kim Y, Toutouzas K, Drakopoulou M, Aggeli C, Felekos I, Nikolaou C, Synetos A, Stathogiannis K, Tsiamis E, Siores E, Stefanadis C, Plicht B, Kahlert P, Grave T, Buck T, Konorza T, Gursoy M, Gokdeniz T, Astarcioglu M, Bayram Z, Cakal B, Karakoyun S, Kalcik M, Acar R, Kahveci G, Ozkan M, Maffessanti F, Tamborini G, Tsang W, Weinert L, Gripari P, Fusini L, Muratori M, Caiani E, Lang R, Pepi M, Yurdakul S, Avci B, Sahin S, Dilekci B, Aytekin S, Ancona R, Comenale Pinto S, Caso P, Arenga F, Coppola M, Rapisarda O, Calabro' R, Hascoet S, Martin R, Dulac Y, Peyre M, Benzouid C, Hadeed K, Acar P, Celutkiene J, Zakarkaite D, Skorniakov V, Zvironaite V, Grabauskiene V, Burca J, Ciparyte L, Laucevicius A, Di Salvo G, Rea A, D'aiello A, Del Gaizo F, Pergola V, D'andrea A, Caso P, Pacileo G, Calabro R, Russo M, Dedobbeleer C, Hadefi A, Naeije R, Unger P, Mornos C, Cozma D, Ionac A, Mornos A, Valcovici M, Pescariu S, Petrescu L, Hu K, Liu D, Niemann M, Herrmann S, Cikes M, Stoerk S, Knop S, Ertl G, Bijnens B, Weidemann F, De Knegt M, Biering-Sorensen T, Sogaard P, Sivertsen J, Jensen J, Mogelvang R, Dedobbeleer C, Hadefi A, Unger P, Naeije R, Lam W, Tang M, Chan K, Yang Y, Fang F, Sun J, Yu C, Lam Y, Panoulas V, Sulemane S, Bratsas A, Konstantinou K, Nihoyannopoulos P, Cimino S, Canali E, Petronilli V, Cicogna F, Arcari L, De Luca L, Francone M, Iacoboni C, Agati L, Schau T, Seifert M, Ridjab D, Schoep M, Gottwald M, Neuss M, Meyhoefer J, Zaenker M, Butter C, Tarr A, Stoebe S, Pfeiffer D, Hagendorff A, Maret E, Ahlander BM, Bjorklund PG, Engvall J, Staskiewicz G, Czekajska-Chehab E, Adamczyk P, Siek E, Przybylski P, Maciejewski R, Drop A, Jimenez Rubio C, Isasti Aizpurua G, Miralles Ibarra J, Al-Mallah M, Somg T, Alam S, Chattahi J, Zweig B, Dhanalakota K, Boedeker S, Ananthasubramaniam K, Park C, March K, Jones S, Mayet J, Tillin T, Chaturvedi N, Hughes A, Hamodraka E, Kallistratos E, Karamanou A, Tsoukas T, Mavropoulos D, Kouremenos N, Zaharopoulou I, Nikolaidis N, Kremastinos D, Manolis A, Loboz-Rudnicka M, Jaroch J, Bociaga Z, Kruszynska E, Ciecierzynska B, Dziuba M, Dudek K, Uchmanowicz I, Loboz-Grudzien K, Silva D, Magalhaes A, Jorge C, Cortez-Dias N, Carrilho-Ferreira P, Silva Marques J, Portela I, Pascoa C, Nunes Diogo A, Brito D, Roosens B, Bala G, Droogmans S, Hostens J, Somja J, Delvenne E, Schiettecatte J, Lahoutte T, Van Camp G, Cosyns B. Poster Session: Right ventricular systolic function. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes268] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Cikes M, Tong L, Jasaityte R, Hamilton J, Sutherland G, D'hooge J, Yurdakul S, Oner F, Avci BK, Sahin S, Direskeneli H, Aytekin S, Fang F, Chan A, Zhang Q, Sanderson J, Kwong J, Yu C, Zaidi A, Raju H, Ghani S, Gati S, Cox A, Sheikh N, Sharma R, Sharma S, Kutty S, Kottam A, Padiyath A, Gao S, Drvol L, Lof J, Li L, Rangamani S, Danford D, Kuehne T, Rosner A, Avenarius D, Malm S, Iqbal A, Baltabaeva A, Schirmer H, Bijnens B, Myrmel T, Magalhaes A, Silva Marques J, Martins S, Carrilho Ferreira P, Jorge C, Silva D, Placido R, Goncalves S, Almeida A, Nunes Diogo A, Poulidakis E, Aggeli C, Sideris S, Dilaveris P, Gatzoulis K, Felekos I, Koutagiar I, Sfendouraki E, Roussakis G, Stefanadis C, Zhang Q, Sun J, Gao R, Feng Y, Liu X, Sheng W, Liu F, Yu C, Hallioglu O, Citirik D, Buyukakilli B, Ozeren M, Gurgul S, Tasdelen B, Rodriguez Lopez A, Rodriguez Lopez A, Garcia Cuenllas L, Garcia Cuenllas L, Medrano C, Medrano C, Granja S, Granja S, Marin C, Marin C, Maroto E, Maroto E, Alvarez T, Alvarez T, Ballesteros F, Ballesteros F, Camino M, Camino M, Centeno M, Centeno M, Alraies M, Aljaroudi W, Halley C, Rodriguez L, Grimm R, Thomas J, Jaber W, Knight D, Coghlan J, Muthurangu V, Grasso A, Toumpanakis C, Caplin M, Taylor A, Davar J, Mohlkert LA, Halvorsen C, Hallberg J, Sjoberg G, Norman M, Cameli M, Losito M, Lisi M, Natali B, Massoni A, Maccherini M, Chiavarelli M, Massetti M, Mondillo S, Sljivic A, Stojcevski B, Celic V, Pencic B, Majstorovic A, Cosic Z, Backovic S, Ilic-Djordjevic I, Muraru D, Gripari P, Esposito R, Tamborini G, Galderisi M, Ermacora D, Maffessanti F, Santoro C, Pepi M, Badano L, Bombardini T, Cini D, Picano E, Shahgaldi K, Gunyeli E, Sahlen A, Manouras A, Winter R, Banovic M, Vukcevic V, Ostojic M, Markovic Z, Mladenovic A, Trifunovic D, Stojkovic S, Bacic D, Dedovic D, Seferovic P, Huttin O, Coulibaly S, Mercy M, Schwartz J, Zinzius P, Sellal J, Popovic B, Marie P, Juilliere Y, Selton-Suty C, Gurzun MM, Ionescu A, Bahlay B, Jones G, Rimbas R, Enescu O, Mihaila S, Ciobanu A, Vinereanu D, Vlasseros I, Koumoulidis A, Tousoulis D, Veioglanis S, Avgeropoulou A, Katsi V, Stefanadis C, Kallikazaros I, Kiviniemi T, Ylitalo A, Airaksinen K, Lehtinen T, Saraste A, Pietila M, Karjalainen P, Trifunovic D, Ostojic M, Stankovic S, Vujisic-Tesic B, Petrovic M, Banovic M, Boricic M, Draganic G, Petrovic M, Stepanovic J, Kuznetsov V, Yaroslavskaya E, Pushkarev G, Krinochkin D, Zyrianov I, Dekleva M, Stevanovic A, Kleut M, Suzic Lazic J, Markovic Nikolic N, Akhunova S, Saifullina G, Sadykov A, Loudon M, D'arcy J, Arnold L, Reynolds R, Mabbet C, Prendergast B, Dahl J, Videbaek L, Poulsen M, Rudbaek T, Pellikka P, Rasmussen L, Moller J, Lowery C, Frenneaux M, Dawson D, Dwivedi G, Singh S, Rudd A, Mahadevan D, Srinivasan J, Jiminez D, Sahinarslan A, Vecchio F, Maccarthy P, Wendler O, Monaghan M, Harimura Y, Seo Y, Ishizu T, Noguchi Y, Aonuma K, Urdaniz MM, Palomares JFR, Rius JB, Surribas IB, Tura GT, Garcia-Moreno LG, Alujas TG, Masip AE, Mas PT, Dorado DG, Meimoun P, Germain A, Clerc J, Elmkies F, Zemir H, Luycx-Bore A, Nasr GM, Erraki A, Dulgheru R, Magne J, Capoulade R, Elhonsali Z, Pierard LA, Pibarot P, Lancellotti P, Wrideier S, Butz T, Schilling I, Gkiouras G, Sasko B, Van Bracht M, Prull M, Trappe HJ, Castillo Bernal F, Mesa Rubio M, Ruiz Ortiz M, Delgado Ortega M, Morenate Navio M, Baeza Garzon M, Del Pino ML, Toledano Delgado F, Mazuelos F, Suarez de Lezo Herreros de Tejada J, Prinz C, Schumann M, Burghardt A, Seggewiss H, Oldenburg O, Horstkotte D, Faber L, Bistola V, Banner N, Hedger M, Simon A, Rahman Haley S, Baltabaeva A, Adamyan K, Tumasyan LR, Chilingaryan A, Makavos G, Kouris N, Kostopoulos V, Stamatelatou M, Damaskos D, Kartsagoulis E, Olympios C, Sade L, Eroglu S, Bircan A, Pirat B, Sezgin A, Aydinalp A, Muderrisoglu H, Sargento L, Satendra M, Sousa C, Longo S, Lousada N, Dos Reis RP, Kuznetsov V, Krinochkin D, Gapon L, Vershinina A, Shurkevich N, Bessonova M, Yaroslavskaya E, Kolunin G, Sargento L, Satendra M, Sousa C, Lousada N, Dos Reis RP, Azevedo O, Lourenco M, Machado I, Guardado J, Medeiros R, Pereira A, Quelhas I, Lourenco A, Duman D, Sargin F, Kilicaslan B, Inan A, Ozgunes N, Goktas P, Ikonomidis I, Tzortzis S, Paraskevaidis I, Andreadou I, Katseli C, Katsimbri P, Papadakis I, Pavlidis G, Anastasiou-Nana M, Lekakis J, Charalampopoulos A, Howard L, Davies R, Gin-Sing W, Tzoulaki I, Grapsa I, Gibbs J, Dobson RA, Cuthbertson DJ, Burgess M, Lichodziejewska B, Kurnicka K, Goliszek S, Kostrubiec M, Dzikowska-Diduch O, Ciurzynski M, Krupa M, Grudzka K, Palczewski P, Pruszczyk P, Mansencal N, Marcadet D, Montalvan B, Dubourg O, Matveeva N, Nartsissova G, Chernjavskiy A, Eicher JC, Berthier S, Lorcerie B, Philip JL, Wolf JE, Wiesen P, Ledoux D, Massion P, Piret S, Canivet JL, Cusma-Piccione M, Zito C, Imbalzano E, Saitta A, Donato D, Madaffari A, Luzza G, Pipitone V, Tripodi R, Carerj S, Bombardini T, Gherardi S, Arpesella G, Maccherini M, Serra W, Del Bene R, Sicari R, Picano E, Al-Mallah M, Ananthasubramaniam K, Alam M, Chattahi J, Zweig B, Boedeker S, Song T, Khoo J, Davies J, Ang KL, Galinanes M, Chin D, Papamichael ND, Karassavidou D, Mpougialkli M, Antoniou S, Giannitsi S, Chachalos S, Gouva C, Naka K, Katopodis K, Michalis L, Tsang W, Cui V, Ionasec R, Takeuchi M, Houle H, Weinert L, Roberson D, Lang R, Altman M, Aussoleil A, Bergerot C, Sibellas F, Bonnefoy-Cudraz E, Derumeaux GA, Thibault H, Mohamed A, Omran A, Hussein M, Shahgaldi K, Gunyeli E, Sahlen A, Manouras A, Winter R, Squeri A, Binno S, Ferdenzi E, Reverberi C, Baldelli M, Barbieri A, Iaccarino D, Naldi M, Bosi S, Kalinowski M, Szulik M, Streb W, Stabryla J, Nowak J, Rybus-Kalinowska B, Kukulski T, Kalarus Z, Ouss A, Riezebos R, Nestaas E, Skranes J, Stoylen A, Brunvand L, Fugelseth D, Magalhaes A, Silva Marques J, Martins S, Carrilho Ferreira P, Placido R, Jorge C, Silva D, Goncalves S, Almeida A, Nunes Diogo A, Nagy A, Kovats T, Apor A, Nagy A, Vago H, Toth A, Toth M, Merkely B, Ranjbar S, Karvandi M, Hassantash S, Da Silva SG, Marin C, Rodriguez A, Marcos C, Rodriguez-Ogando A, Maroto E, Medrano C, Del Valle DI, Lopez-Fernandez T, Gemma D, Gomez-Rubin M, De Torres F, Feliu J, Canales M, Buno A, Ramirez E, Lopez-Sendon J, Magalhaes A, Silva Marques J, Martins S, Placido R, Silva D, Jorge C, Calisto C, Goncalves S, Almeida A, Nunes Diogo A, Jorge C, Cortez-Dias N, Goncalves S, Ribeiro S, Santos L, Silva D, Barreiros C, Bernardes A, Carpinteiro L, Sousa J, Kim SH, Choi W, Chidambaram S, Arunkumar R, Venkatesan S, Gnanavelu G, Dhandapani V, Ravi M, Karthikeyan G, Meenakshi K, Muthukumar D, Swaminathan N, Vitarelli A, Barilla F, Capotosto L, Truscelli G, Dettori O, Caranci F, D-Angeli I, De Maio M, De Cicco V, Bruno P, Doesch C, Sueselbeck T, Haghi D, Streitner F, Borggrefe M, Papavassiliu T, Laser K, Schaefer F, Fischer M, Habash S, Degener F, Moysich A, Haas N, Kececioglu D, Burchert W, Koerperich H, Dwivedi G, Al-Shehri H, Dekemp R, Ali I, Alghamdi A, Klein R, Scullion A, Beanlands R, Ruddy T, Chow B, Lipiec P, Szymczyk E, Michalski B, Wozniakowski B, Rotkiewicz A, Stefanczyk L, Szymczyk K, Kasprzak J, Angelov A, Yotov Y, Mircheva L, Kisheva A, Kunchev O, Ikonomidis I, Tsantes A, Triantafyllidi H, Tzortzis S, Dima K, Trivilou P, Papadopoulos C, Travlou A, Anastasiou-Nana M, Lekakis J, Bader R, Agoston-Coldea L, Lupu S, Mocan T, Loegstrup B, Hofsten D, Christophersen T, Moller J, Bjerre M, Flyvbjerg A, Botker H, Egstrup K, Park Y, Choi J, Yun K, Lee S, Han D, Kim J, Kim J, Kim J, Chun K. Poster Session Wednesday 5 December all day Display * Determinants of left ventricular performance. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes248] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Ernande L, Thibault H, Bergerot C, Moulin P, Wen H, Derumeaux G, Croisille P. Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: identification at MR imaging with cine displacement encoding with stimulated echoes. Radiology 2012; 265:402-9. [PMID: 22929334 DOI: 10.1148/radiol.12112571] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
PURPOSE To determine if cine displacement encoding with stimulated echoes (DENSE) can help to identify and determine the patterns of subclinical myocardial systolic dysfunction in patients with type 2 diabetes mellitus (DM) when compared with cine DENSE in control patients. MATERIALS AND METHODS After obtaining approval from the institutional ethics committee and written informed consent from the patients, 37 patients with type 2 DM without overt heart disease and 23 age-matched control patients were prospectively included in the study. The patients underwent standard cine magnetic resonance (MR) imaging with two-dimensional cine DENSE acquisitions. Circumferential (Ecc) and radial (Err) systolic strains were measured on short-axis views at basal, mid, and apical left ventricular levels. Longitudinal strain (Ell) was measured on four- and two-chamber views. Statistical testing included the intraclass correlation coefficient and multiple linear regression analysis. RESULTS The intraobserver intraclass correlation coefficient values were 0.85, 0.95, and 0.90, and the interobserver intraclass correlation coefficient values were 0.79, 0.91 and 0.80 for Ecc, Err, and Ell, respectively. The left ventricular ejection fraction was in the reference range and similar between the groups, and the patients with DM showed a decrease in Ecc (-14.4%±1.6 vs -17.0%±1.6, P<.001), Err (36.2%±10.9 vs 44.4%±9.9, P=.006) and Ell (-12.9%±2.1 vs -15.5%±1.6, P<.001) compared with the control patients. Finally, DM was independently associated with Ecc (P<.001), Err (P=.05) and Ell (P=.01) after adjustment for age, sex, hypertension, body mass index, and left ventricular mass. CONCLUSION Cine DENSE, a motion-encoding MR imaging technique for myocardial strain assessment with high spatial resolution, appears to be useful in the identification of subclinical myocardial dysfunction in patients with DM.
Collapse
Affiliation(s)
- Laura Ernande
- Service des Explorations Fonctionnelles Cardiovasculaires, Department of Endocrinology, Louis Pradel Hospital, CarMeN INSERM Unit 1060, Université de Lyon, Lyon, France
| | | | | | | | | | | | | |
Collapse
|
42
|
Bejan-Angoulvant T, Bergerot C, Juillard L, Mezergues A, Morelon E, Pouteil-Noble C, André-Fouët X, Angoulvant D. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study. Nephrol Dial Transplant 2012; 27:2886-91. [PMID: 22344775 DOI: 10.1093/ndt/gfs008] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Myocardial ischaemia, a consequence of coronary artery disease, is a major cause of death in patients with end-stage renal disease (ESRD). The pathophysiology and clinical presentation of coronary artery disease in ESRD patients seem to differ from non-ESRD patients with higher implication of myocardial microvascular disease (MMD), higher mortality, fewer myocardial infarctions, less significant coronary stenosis and low efficacy of well-established drugs such as statin and angiotensin-converting enzyme inhibitors. No study has investigated the presence of MMD and its clinical impact in ESRD patients. METHODS We designed an observational prospective cohort study to investigate the prevalence of MMD and its association with major adverse cardiovascular events (MACE) in ESRD patients with a positive non-invasive test for myocardial ischaemia. Patients eligible for inclusion are those>18 years old receiving dialysis and/or undergoing investigation for kidney transplantation, who are referred to our renal clinic and meet all the inclusion criteria but none of the exclusion criteria. Patients with a positive test for myocardial ischaemia will be enrolled in the 'invasive group'. They will be further examined to detect simultaneously epicardial coronary stenosis by coronary angiography and MMD using pressure wire measurement of fractional flow reserve and coronary flow reserve followed by calculation of the index of microcirculatory resistance. Patients with a negative test for myocardial ischaemia will be enrolled in a 'control group' designed to verify whether the invasive group is indeed at high risk for MACE. Both groups will be followed up for 2 years to compare the incidence of MACE. CONCLUSION The MICROCARD study will phenotype MMD and will investigate its relation with the incidence of MACE in ESRD patients with myocardial ischaemia. Clinicaltrial.gov NCT01291771.
Collapse
|
43
|
Angoulvant D, Bergerot C, Mézergues A, André-Fouët X, Bejan-Angoulvant T. 049 Invasive detection of myocardial microvascular disease in patients with end stage renal disease. The MICROCARD study. Archives of Cardiovascular Diseases Supplements 2012. [DOI: 10.1016/s1878-6480(12)70445-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
44
|
Thuny F, Potton L, Rapacchi S, Thibault H, Bergerot C, Viallon M, Mewton N, Ovize M, Derumeaux G, Croisille P. Myocardial T1-mapping for early detection of left ventricular myocardial fibrosis in systemic sclerosis. J Cardiovasc Magn Reson 2011. [PMCID: PMC3106596 DOI: 10.1186/1532-429x-13-s1-m10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
|
45
|
Thibault H, Ernande L, Rapacchi S, Viallon M, Bergerot C, Thuny F, Ovize M, Wen H, Derumeaux G, Croisille P. Early detection of myocardial fibrosis in type II diabetic patients using MR T1-mapping. J Cardiovasc Magn Reson 2011. [PMCID: PMC3106640 DOI: 10.1186/1532-429x-13-s1-o110] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
46
|
Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, Croisille P, Ovize M, Groisne L, Moulin P, Gillebert TC, Derumeaux G. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr 2011; 24:1268-1275.e1. [PMID: 21907542 DOI: 10.1016/j.echo.2011.07.017] [Citation(s) in RCA: 158] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2011] [Indexed: 01/07/2023]
Abstract
BACKGROUND Diastolic dysfunction is considered the first marker of diabetic cardiomyopathy. However, preclinical systolic alteration was also recently described by strain, but its association with diastolic dysfunction has never been investigated. METHODS One hundred fourteen patients with type 2 diabetes mellitus (DM) with controlled blood pressure and without overt heart disease were prospectively enrolled and compared with 88 age-matched controls. All subjects underwent comprehensive echocardiography, including diastolic evaluation according to current recommendations and speckle-tracking imaging. The prevalence of diastolic dysfunction, the determinants of diastolic parameters, and the association between preclinical systolic and diastolic dysfunctions were studied. RESULTS Diastolic parameters were altered in patients compared with controls, with lower E/A ratios, longer mitral deceleration and isovolumic relaxation times, and higher E/e' ratio. Diastolic dysfunction occurred in 47% of patients with DM (33% and 14% with grade I and II diastolic dysfunction, respectively) and systolic alteration (longitudinal strain ≥ -18%) in 32% of patients. Whereas longitudinal systolic strain was independently associated with DM and gender, diastolic parameters were influenced by many factors, including age, rate-pressure product, history of hypertension, and body mass index. Systolic alteration occurred in 28% of patients with DM with normal diastolic function and in 35% with diastolic dysfunction. CONCLUSIONS Diastolic dysfunction diagnosed according to current recommendations is frequent in patients with DM but is also influenced by other factors. Systolic strain alteration may exist despite normal diastolic function, indicating that diastolic dysfunction should not be considered the first marker of a preclinical form of diabetic cardiomyopathy.
Collapse
Affiliation(s)
- Laura Ernande
- Service des Explorations Fonctionnelles Cardiovasculaires, Louis Pradel Hospital, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Thibault H, Gomez L, Bergerot C, Augeul L, Scherrer-Crosbie M, Ovize M, Derumeaux G. Strain-Rate Imaging Predicts the Attenuation of Left Ventricular Remodeling Induced by Ischemic Postconditioning After Myocardial Infarction in Mice. Circ Cardiovasc Imaging 2011; 4:550-7. [DOI: 10.1161/circimaging.110.962282] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Hélène Thibault
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Ludovic Gomez
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Cyrille Bergerot
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Lionel Augeul
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Marielle Scherrer-Crosbie
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Michel Ovize
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| | - Geneviève Derumeaux
- From Université Claude Bernard Lyon I, France, U1060-CARMEN, Cardioprotection, Lyon, France (H.T., L.G., L.A., M.O., G.D.); Service des Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (H.T., C.B., M.O., G.D.); and Massachusetts General Hospital, Boston, MA (M.S.C.)
| |
Collapse
|
48
|
Ernande L, Wen H, Bergerot C, Thibault H, Ovize M, Derumeaux G, Croisille P. Cine Displacement ENcoding imaging with Stimulated Echoes (cine-DENSE) confirms systolic myocardial dysfunction in asymptomatic patients with type 2 diabetes mellitus: comparison with MR-tagging. J Cardiovasc Magn Reson 2011. [PMCID: PMC3106941 DOI: 10.1186/1532-429x-13-s1-p280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
49
|
Ernande L, Rietzschel ER, Bergerot C, De Buyzere ML, Schnell F, Groisne L, Ovize M, Croisille P, Moulin P, Gillebert TC, Derumeaux G. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J Am Soc Echocardiogr 2010; 23:1266-72. [PMID: 20932716 DOI: 10.1016/j.echo.2010.09.007] [Citation(s) in RCA: 120] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2010] [Indexed: 12/23/2022]
Abstract
BACKGROUND Diabetic cardiomyopathy has been characterized by an early impairment of left ventricular (LV) longitudinal function as opposed to preserved LV radial function. METHODS Conventional echocardiography and longitudinal (ε(L)) and radial (ε(R)) systolic strain assessed by speckle-tracking imaging were obtained in 114 type 2 diabetic patients and 88 age-matched controls. RESULTS LV ejection fraction was similar in diabetic patients and controls. The presence of subclinical LV systolic dysfunction in diabetic patients was demonstrated by lower values of midwall fractional shortening (18% ± 3% vs 20% ± 3%, P = .006), ε(L) (-19% ± 3% vs -22% ± 2%, P < .001), and ε(R) (50% ± 16% vs 56% ± 12%, P = .003) compared with controls. On multivariate analysis, factors predicting strain values were diabetes (P = .001) and gender (P = .001) for ε(L) and diabetes (P = .003) for ε(R). CONCLUSION Diabetic patients without overt heart disease display subclinical alteration of both radial and longitudinal LV systolic function even after adjustment for blood pressure, age, and body mass index.
Collapse
Affiliation(s)
- Laura Ernande
- Centre d'Investigations Cliniques 0201, Louis Pradel Hospital, Lyon, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Perret X, Bergerot C, Rioufol G, Bonvini RF, Ovize M, Finet G. Same-day-discharge ad hoc percutaneous coronary intervention: Initial single-centre experience. Arch Cardiovasc Dis 2009; 102:743-8. [DOI: 10.1016/j.acvd.2009.09.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2008] [Revised: 09/02/2009] [Accepted: 09/03/2009] [Indexed: 10/20/2022]
|